The global digital pathology market is expected to grow steadily from USD 1.58 billion in 2026 to USD 2.86 billion by 2031, at a CAGR of 12.5% during the forecast period. The major market driver is the increasing adoption of technologies such as AI, machine learning, cloud-based platforms, and whole-slide imaging systems in pathology practices. Widespread acceptance of digitalization in laboratories and hospitals within the healthcare sector is one of the most significant drivers of market growth. Digital pathology involves scanning, storage, and analysis of tissue slides using digital methods, thereby reducing reliance on microscopy. This improves workflow efficiency and helps pathologists share cases more easily, enabling faster, more accurate diagnosis. ![Digital Pathology Market]( "Digital Pathology Market")
Many healthcare systems in the region are transitioning from traditional microscopy to digital pathology platforms, enabling faster image sharing, remote consultation, and improved diagnostic accuracy. This shift is helping hospitals handle rising patient volumes more efficiently. Government initiatives are also playing a major role in market growth. Several countries in the region are promoting digital health adoption through healthcare regulations, funding programs, and national health modernization plans. These initiatives are encouraging hospitals and laboratories to adopt digital pathology systems, especially for cancer diagnosis and large-scale screening programs.
Brightfield scanners are projected to form the largest segment among whole-slide imaging scanners in the digital pathology market
Based on whole-slide imaging scanners, brightfield scanners are expected to dominate the market share during the forecast period. Brightfield scanners are expected to be the dominant segment, mainly because brightfield scanning technology is one of the most widely adopted and standardized technologies for routine pathology workflows in hospitals and diagnostic laboratories. Brightfield scanners are usually employed to produce digital images of stained tissue slides, such as hematoxylin and eosin (H&E) stained slides. The digital images produced by brightfield scanners resemble those that pathologists see under a microscope. Due to this reason, the adoption of brightfield scanners has been relatively easy. High accuracy of brightfield scanners has been another important driver for growth in the market.By Type, human pathology accounted for the highest share of the digital pathology market
Based on the type, human pathology accounted for the highest share due to the growing prevalence of chronic and complicated disorders such as cancer. With the growing number of cancer patients, cardiovascular diseases, and other chronic conditions in the global population, there has been a rise in the amount of tissue analysis in hospitals and diagnostic labs. Therefore, there is a high demand for quick and reliable diagnosis methods, which is leading to a rapid adoption of digital pathology in human health care. The use of advanced technologies such as imaging and Artificial Intelligence (AI)-based diagnostic tools is another factor that is fueling the market. Such technologies aid pathologists in analyzing slides faster, recognizing abnormalities, and decision-making in complicated cases.APAC to witness the highest growth rate during the forecast period.
In this report, the digital pathology market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The digital pathology market in APAC is projected to register the highest CAGR during the forecast period. The growth in the APAC market is mainly driven by an increasing focus on digital transformation in hospitals and diagnostic laboratories.Many healthcare systems in the region are transitioning from traditional microscopy to digital pathology platforms, enabling faster image sharing, remote consultation, and improved diagnostic accuracy. This shift is helping hospitals handle rising patient volumes more efficiently. Government initiatives are also playing a major role in market growth. Several countries in the region are promoting digital health adoption through healthcare regulations, funding programs, and national health modernization plans. These initiatives are encouraging hospitals and laboratories to adopt digital pathology systems, especially for cancer diagnosis and large-scale screening programs.
The breakdown of primary participants is as mentioned below:
- By Company Type - Tier 1: 46%, Tier 2: 34%, and Tier 3: 20%
- By Designation - C-level: 35%, Director-level: 25%, and Others: 40%
- By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.
Danaher Corporation (US) & F. Hoffmann-La Roche Ltd (Switzerland) are some of the key players in the digital pathology market.
- The study includes an in-depth competitive analysis of these key players in the digital pathology market, with their company profiles, recent developments, and key market strategies.
Research Coverage
This research report categorizes the digital pathology market by product (hardware, software, storage systems) by type (human pathology, and veterinary pathology), by technology (conventional digital pathology, AI- enabled digital pathology), by application (clinical diagnostics, pre-clinical research, clinical trials, Telepathology, Academic & Translational Research, Education & Training, Others), by therapeutic area (oncology, hematology, gastrointestinal diseases, infectious diseases, neurology, others), by end-user (hospitals & health systems, diagnostic & reference laboratories, veterinary laboratories, pharmaceutical & biotechnology companies, contract research organizations (CROs), academic & research institutes, others), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the digital pathology market. A detailed analysis of the key industry players has been conducted to provide insights into their business overview, solutions, key strategies, contracts, partnerships, and agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the digital pathology market. This report covers competitive analysis of upcoming startups in the digital pathology market ecosystem.Reasons to buy this report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the digital pathology market and the subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.The report provides insights into the following pointers:
- Analysis of key drivers (AI-enabled digital pathology improving laboratory throughput, workflow efficiency, and diagnostic accuracy; rising burden of cancer and other chronic diseases increasing pathology testing volumes; expanding adoption of digital pathology in drug discovery, biomarker validation, and clinical research, etc.), restraints (high initial capital investment for scanners, software platforms, and storage infrastructure; data interoperability issues with legacy laboratory and healthcare information systems), opportunities (affordable scanner development enabling adoption in low-resource settings; growth of cloud-native digital pathology platforms and SaaS-based deployment models, etc.), challenges (algorithm validation, explainability, and clinical trust in AI-assisted diagnostics; data privacy, cybersecurity, and patient information protection concerns, etc.)
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the digital pathology market
- Market Development: Comprehensive information about lucrative markets - the report analyses the digital pathology market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the digital pathology market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), Koninklijke Philips N.V. (Netherlands), Sectra AB (Sweden), Hamamatsu Photonics (Japan), Fujifilm Holdings Corporation (Japan), among others, in the digital pathology market
Table of Contents
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 DIGITAL PATHOLOGY MARKET OVERVIEW
3.2 DIGITAL PATHOLOGY MARKET, BY PRODUCT & REGION
3.3 DIGITAL PATHOLOGY MARKET: GEOGRAPHIC SNAPSHOT
3.2 DIGITAL PATHOLOGY MARKET, BY PRODUCT & REGION
3.3 DIGITAL PATHOLOGY MARKET: GEOGRAPHIC SNAPSHOT
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 AI-enabled digital pathology improving laboratory throughput, workflow efficiency, and diagnostic accuracy
4.2.1.2 Rising burden of cancer and other chronic diseases
4.2.1.3 Expanding adoption of digital pathology in drug discovery, biomarker validation, and clinical research
4.2.1.4 Growing adoption of computational pathology and advanced image analysis technologies
4.2.1.5 Increasing shortage of pathologists driving laboratory digitization and workflow automation
4.2.1.6 Rising adoption of telepathology and remote diagnostic workflows
4.2.1.7 Growing integration of digital pathology with EHR, PACS, and laboratory information systems
4.2.1.8 National cancer screening programs and healthcare digitalization initiatives
4.2.2 RESTRAINTS
4.2.2.1 High initial capital investment for scanners, software platforms, and storage infrastructure
4.2.2.2 Data interoperability issues with legacy laboratory and healthcare information systems
4.2.2.3 Regulatory and reimbursement uncertainties across key markets
4.2.2.4 Large-scale image storage, archiving, and data management requirements
4.2.2.5 Limited standardization across digital pathology workflows, image formats, and deployment practices
4.2.3 OPPORTUNITIES
4.2.3.1 Growing adoption of digital biomarkers in drug development and clinical research
4.2.3.2 Increasing utilization of companion diagnostics and precision oncology applications
4.2.3.3 Growth of cloud-native digital pathology platforms and SaaS-based deployment models
4.2.3.4 Affordable scanner development enabling adoption in low-resource settings
4.2.4 CHALLENGES
4.2.4.1 Shortage of skilled pathologists and technicians
4.2.4.2 Algorithm validation, explainability, and clinical trust in Al-assisted diagnostics
4.2.4.3 Data privacy, cybersecurity, and patient information protection concerns
4.2.4.4 Integration complexity across heterogeneous healthcare IT environments
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 AI-enabled digital pathology improving laboratory throughput, workflow efficiency, and diagnostic accuracy
4.2.1.2 Rising burden of cancer and other chronic diseases
4.2.1.3 Expanding adoption of digital pathology in drug discovery, biomarker validation, and clinical research
4.2.1.4 Growing adoption of computational pathology and advanced image analysis technologies
4.2.1.5 Increasing shortage of pathologists driving laboratory digitization and workflow automation
4.2.1.6 Rising adoption of telepathology and remote diagnostic workflows
4.2.1.7 Growing integration of digital pathology with EHR, PACS, and laboratory information systems
4.2.1.8 National cancer screening programs and healthcare digitalization initiatives
4.2.2 RESTRAINTS
4.2.2.1 High initial capital investment for scanners, software platforms, and storage infrastructure
4.2.2.2 Data interoperability issues with legacy laboratory and healthcare information systems
4.2.2.3 Regulatory and reimbursement uncertainties across key markets
4.2.2.4 Large-scale image storage, archiving, and data management requirements
4.2.2.5 Limited standardization across digital pathology workflows, image formats, and deployment practices
4.2.3 OPPORTUNITIES
4.2.3.1 Growing adoption of digital biomarkers in drug development and clinical research
4.2.3.2 Increasing utilization of companion diagnostics and precision oncology applications
4.2.3.3 Growth of cloud-native digital pathology platforms and SaaS-based deployment models
4.2.3.4 Affordable scanner development enabling adoption in low-resource settings
4.2.4 CHALLENGES
4.2.4.1 Shortage of skilled pathologists and technicians
4.2.4.2 Algorithm validation, explainability, and clinical trust in Al-assisted diagnostics
4.2.4.3 Data privacy, cybersecurity, and patient information protection concerns
4.2.4.4 Integration complexity across heterogeneous healthcare IT environments
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF SUPPLIERS
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.3.1 RESEARCH & PRODUCT DEVELOPMENT
5.3.2 COMPONENT AND TECHNOLOGY INFRASTRUCTURE
5.3.3 PLATFORM DEVELOPMENT AND INTEGRATION
5.3.4 DISTRIBUTION
5.3.5 MARKETING AND SALES
5.3.6 POST-SALE SERVICES
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
5.5.1 INDICATIVE PRICING FOR DIGITAL PATHOLOGY PRODUCTS, BY KEY PLAYERS (2025)
5.5.2 INDICATIVE PRICING FOR DIGITAL PATHOLOGY PRODUCTS, BY REGION (2025)
5.6 TRADE ANALYSIS
5.6.1 IMPORT DATA (HS CODE 901180)
5.6.2 EXPORT DATA (HS CODE 901180)
5.7 KEY CONFERENCES AND EVENTS, 2026-2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9 INVESTMENT AND FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
5.11 IMPACT OF 2025 US TARIFF - DIGITAL PATHOLOGY MARKET
5.11.1 INTRODUCTION
5.11.2 KEY TARIFF RATES
5.11.3 PRICE IMPACT ANALYSIS
5.11.4 IMPACT ON COUNTRY/REGION
5.11.4.1 US
5.11.4.2 Europe
5.11.4.3 Asia Pacific
5.11.5 IMPACT ON END USERS
5.11.5.1 Hospitals and health systems
5.11.5.2 Diagnostic and reference laboratories
5.11.5.3 Veterinary laboratories
5.11.5.4 Pharmaceutical and biotechnology companies
5.11.5.5 Contract research organizations
5.11.5.6 Academic and research institutes
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF SUPPLIERS
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.3.1 RESEARCH & PRODUCT DEVELOPMENT
5.3.2 COMPONENT AND TECHNOLOGY INFRASTRUCTURE
5.3.3 PLATFORM DEVELOPMENT AND INTEGRATION
5.3.4 DISTRIBUTION
5.3.5 MARKETING AND SALES
5.3.6 POST-SALE SERVICES
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
5.5.1 INDICATIVE PRICING FOR DIGITAL PATHOLOGY PRODUCTS, BY KEY PLAYERS (2025)
5.5.2 INDICATIVE PRICING FOR DIGITAL PATHOLOGY PRODUCTS, BY REGION (2025)
5.6 TRADE ANALYSIS
5.6.1 IMPORT DATA (HS CODE 901180)
5.6.2 EXPORT DATA (HS CODE 901180)
5.7 KEY CONFERENCES AND EVENTS, 2026-2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9 INVESTMENT AND FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
5.11 IMPACT OF 2025 US TARIFF - DIGITAL PATHOLOGY MARKET
5.11.1 INTRODUCTION
5.11.2 KEY TARIFF RATES
5.11.3 PRICE IMPACT ANALYSIS
5.11.4 IMPACT ON COUNTRY/REGION
5.11.4.1 US
5.11.4.2 Europe
5.11.4.3 Asia Pacific
5.11.5 IMPACT ON END USERS
5.11.5.1 Hospitals and health systems
5.11.5.2 Diagnostic and reference laboratories
5.11.5.3 Veterinary laboratories
5.11.5.4 Pharmaceutical and biotechnology companies
5.11.5.5 Contract research organizations
5.11.5.6 Academic and research institutes
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 CLOUD STORAGE & ARCHIVING
6.1.2 WHOLE SLIDE IMAGING (WSI) SCANNERS
6.1.3 IMAGE MANAGEMENT SYSTEMS
6.1.4 AI-ENABLED IMAGE ANALYSIS & COMPUTATIONAL PATHOLOGY PLATFORMS
6.1.5 COMPLEMENTARY TECHNOLOGIES
6.1.5.1 LIS, EHR, and PACS integration
6.1.5.2 Digital biomarker platform
6.1.5.3 Companion diagnostic platforms
6.1.5.4 Telepathology & remote collaboration platforms
6.1.6 ADJACENT TECHNOLOGIES
6.1.6.1 Genomic sequencing
6.1.6.2 Multi-omics platforms
6.1.6.3 Precision medicine platforms
6.2 TECHNOLOGY/PRODUCT ROADMAP
6.3 PATENT ANALYSIS
6.3.1 PATENT PUBLICATION TRENDS FOR DIGITAL PATHOLOGY MARKET
6.3.2 DIGITAL PATHOLOGY PATENTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.4 FUTURE APPLICATIONS
6.4.1 AI-DRIVEN DIAGNOSTIC DECISION SUPPORT
6.4.2 PRECISION MEDICINE & DIGITAL BIOMARKER DEVELOPMENT
6.4.3 INTEGRATED PATHOLOGY FOR DRUG DEVELOPMENT & CLINICAL RESEARCH
6.5 IMPACT OF GEN AI IN DIGITAL PATHOLOGY MARKET
6.5.1 INTRODUCTION
6.5.2 MARKET POTENTIAL OF AI/GEN AI IN DIGITAL PATHOLOGY MARKET
6.5.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
6.5.3.1 AI-Powered Computational Pathology for Biomarker Discovery at PathAI
6.5.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
6.5.4.1 AI & computational pathology software market
6.5.4.2 Telepathology & remote collaboration market
6.5.4.3 Digital biomarker market
6.5.5 USER READINESS AND IMPACT ASSESSMENT
6.5.5.1 User readiness
6.5.5.2 Hospitals & health systems
6.5.5.3 Diagnostic & reference laboratories
6.5.5.4 Veterinary laboratories
6.5.5.5 Pharmaceutical & biotechnology companies
6.5.5.6 Contract research organizations (CROs)
6.5.5.7 Academic & research institutes
6.5.5.8 Impact assessment
6.5.5.9 User A: Hospitals and health systems
6.5.5.9.1 Implementation
6.5.5.9.2 Impact
6.5.5.10 User B: Diagnostic & reference laboratories
6.5.5.10.1 Implementation
6.5.5.10.2 Impact
6.5.5.11 User C: Veterinary laboratories
6.5.5.11.1 Implementation
6.5.5.11.2 Impact
6.5.5.12 User D: Pharmaceutical & biotechnology companies
6.5.5.12.1 Implementation
6.5.5.12.2 Impact
6.5.5.13 User E: Contract Research Organizations
6.5.5.13.1 Implementation
6.5.5.13.2 Impact
6.5.5.14 User F: Academic & research institutes
6.5.5.14.1 Implementation
6.5.5.14.2 Impact
6.1.1 CLOUD STORAGE & ARCHIVING
6.1.2 WHOLE SLIDE IMAGING (WSI) SCANNERS
6.1.3 IMAGE MANAGEMENT SYSTEMS
6.1.4 AI-ENABLED IMAGE ANALYSIS & COMPUTATIONAL PATHOLOGY PLATFORMS
6.1.5 COMPLEMENTARY TECHNOLOGIES
6.1.5.1 LIS, EHR, and PACS integration
6.1.5.2 Digital biomarker platform
6.1.5.3 Companion diagnostic platforms
6.1.5.4 Telepathology & remote collaboration platforms
6.1.6 ADJACENT TECHNOLOGIES
6.1.6.1 Genomic sequencing
6.1.6.2 Multi-omics platforms
6.1.6.3 Precision medicine platforms
6.2 TECHNOLOGY/PRODUCT ROADMAP
6.3 PATENT ANALYSIS
6.3.1 PATENT PUBLICATION TRENDS FOR DIGITAL PATHOLOGY MARKET
6.3.2 DIGITAL PATHOLOGY PATENTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.4 FUTURE APPLICATIONS
6.4.1 AI-DRIVEN DIAGNOSTIC DECISION SUPPORT
6.4.2 PRECISION MEDICINE & DIGITAL BIOMARKER DEVELOPMENT
6.4.3 INTEGRATED PATHOLOGY FOR DRUG DEVELOPMENT & CLINICAL RESEARCH
6.5 IMPACT OF GEN AI IN DIGITAL PATHOLOGY MARKET
6.5.1 INTRODUCTION
6.5.2 MARKET POTENTIAL OF AI/GEN AI IN DIGITAL PATHOLOGY MARKET
6.5.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
6.5.3.1 AI-Powered Computational Pathology for Biomarker Discovery at PathAI
6.5.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
6.5.4.1 AI & computational pathology software market
6.5.4.2 Telepathology & remote collaboration market
6.5.4.3 Digital biomarker market
6.5.5 USER READINESS AND IMPACT ASSESSMENT
6.5.5.1 User readiness
6.5.5.2 Hospitals & health systems
6.5.5.3 Diagnostic & reference laboratories
6.5.5.4 Veterinary laboratories
6.5.5.5 Pharmaceutical & biotechnology companies
6.5.5.6 Contract research organizations (CROs)
6.5.5.7 Academic & research institutes
6.5.5.8 Impact assessment
6.5.5.9 User A: Hospitals and health systems
6.5.5.9.1 Implementation
6.5.5.9.2 Impact
6.5.5.10 User B: Diagnostic & reference laboratories
6.5.5.10.1 Implementation
6.5.5.10.2 Impact
6.5.5.11 User C: Veterinary laboratories
6.5.5.11.1 Implementation
6.5.5.11.2 Impact
6.5.5.12 User D: Pharmaceutical & biotechnology companies
6.5.5.12.1 Implementation
6.5.5.12.2 Impact
6.5.5.13 User E: Contract Research Organizations
6.5.5.13.1 Implementation
6.5.5.13.2 Impact
6.5.5.14 User F: Academic & research institutes
6.5.5.14.1 Implementation
6.5.5.14.2 Impact
7 REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS AND COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 REGULATORY FRAMEWORK
7.1.2.1 North America
7.1.2.2 Europe
7.1.2.3 Asia Pacific
7.1.2.4 Latin America
7.1.2.5 Middle East & Africa
7.1.3 INDUSTRY STANDARDS
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 REGULATORY FRAMEWORK
7.1.2.1 North America
7.1.2.2 Europe
7.1.2.3 Asia Pacific
7.1.2.4 Latin America
7.1.2.5 Middle East & Africa
7.1.3 INDUSTRY STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 INTRODUCTION
8.2 DECISION-MAKING PROCESS
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.3.2 BUYING CRITERIA
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5.1 UNMET NEEDS
8.5.2 END USER EXPECTATIONS
8.6 MARKET PROFITABILITY
8.2 DECISION-MAKING PROCESS
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.3.2 BUYING CRITERIA
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5.1 UNMET NEEDS
8.5.2 END USER EXPECTATIONS
8.6 MARKET PROFITABILITY
9 DIGITAL PATHOLOGY MARKET, BY PRODUCT
9.1 INTRODUCTION
9.2 HARDWARE
9.2.1 DIGITIZATION OF PATHOLOGY WORKFLOWS AND INCREASING INSTALLATION OF WHOLE-SLIDE IMAGING SYSTEMS TO BOOST MARKET
9.2.2 WHOLE SLIDE IMAGING SCANNERS
9.2.2.1 Increasing pathology workloads & need for remote consultation driving demand
9.2.2.2 Brightfield scanners
9.2.2.2.1 Cost-efficient features to boost demand
9.2.2.3 Fluorescence scanners
9.2.2.3.1 Ability to detect cellular structures and biomarkers to fuel uptake
9.2.2.4 Other scanners
9.2.3 WORKSTATIONS & VIEWING SYSTEMS
9.2.3.1 Rising demand for digital pathology visualization and collaboration tools
9.2.4 PERIPHERALS & ACCESSORIES
9.2.4.1 Growing laboratory automation and workflow digitization support adoption of pathology accessories
9.3 SOFTWARE
9.3.1 INCREASING DEMAND FOR REMOTE WORK AND CONSULTATIONS TO BOOST DEMAND
9.3.1.1 Enterprise digital pathology solutions/platforms
9.3.1.1.1 Growing enterprise-wide digital transformation initiatives drive adoption of integrated pathology platforms
9.3.1.2 Image Management Software
9.3.1.2.1 Increasing digital slide volumes drive demand for scalable image management solutions
9.3.1.3 Image analysis software
9.3.1.3.1 Ability to automate quantitative evaluation to support market growth
9.3.1.4 AI & computational pathology software
9.3.1.4.1 Growing adoption of AI-assisted diagnostics drives rapid market expansion
9.4 STORAGE SYSTEMS
9.4.1 GROWING FOCUS ON STORAGE OF HIGH-RESOLUTION IMAGES TO DRIVE MARKET
9.4.1.1 On-premise Storage
9.4.1.1.1 Data security, regulatory compliance, and direct infrastructure control support continued adoption
9.4.1.2 Cloud Storage
9.4.1.2.1 Scalability, remote accessibility, and cost-efficient data management driving growth of cloud-based storage solutions
9.4.1.3 Hybrid storage
9.4.1.3.1 Balance of performance, scalability, and compliance requirements accelerate adoption
9.2 HARDWARE
9.2.1 DIGITIZATION OF PATHOLOGY WORKFLOWS AND INCREASING INSTALLATION OF WHOLE-SLIDE IMAGING SYSTEMS TO BOOST MARKET
9.2.2 WHOLE SLIDE IMAGING SCANNERS
9.2.2.1 Increasing pathology workloads & need for remote consultation driving demand
9.2.2.2 Brightfield scanners
9.2.2.2.1 Cost-efficient features to boost demand
9.2.2.3 Fluorescence scanners
9.2.2.3.1 Ability to detect cellular structures and biomarkers to fuel uptake
9.2.2.4 Other scanners
9.2.3 WORKSTATIONS & VIEWING SYSTEMS
9.2.3.1 Rising demand for digital pathology visualization and collaboration tools
9.2.4 PERIPHERALS & ACCESSORIES
9.2.4.1 Growing laboratory automation and workflow digitization support adoption of pathology accessories
9.3 SOFTWARE
9.3.1 INCREASING DEMAND FOR REMOTE WORK AND CONSULTATIONS TO BOOST DEMAND
9.3.1.1 Enterprise digital pathology solutions/platforms
9.3.1.1.1 Growing enterprise-wide digital transformation initiatives drive adoption of integrated pathology platforms
9.3.1.2 Image Management Software
9.3.1.2.1 Increasing digital slide volumes drive demand for scalable image management solutions
9.3.1.3 Image analysis software
9.3.1.3.1 Ability to automate quantitative evaluation to support market growth
9.3.1.4 AI & computational pathology software
9.3.1.4.1 Growing adoption of AI-assisted diagnostics drives rapid market expansion
9.4 STORAGE SYSTEMS
9.4.1 GROWING FOCUS ON STORAGE OF HIGH-RESOLUTION IMAGES TO DRIVE MARKET
9.4.1.1 On-premise Storage
9.4.1.1.1 Data security, regulatory compliance, and direct infrastructure control support continued adoption
9.4.1.2 Cloud Storage
9.4.1.2.1 Scalability, remote accessibility, and cost-efficient data management driving growth of cloud-based storage solutions
9.4.1.3 Hybrid storage
9.4.1.3.1 Balance of performance, scalability, and compliance requirements accelerate adoption
10 DIGITAL PATHOLOGY MARKET, BY TYPE
10.1 INTRODUCTION
10.2 HUMAN PATHOLOGY
10.2.1 INCREASING CANCER RESEARCH ACTIVITIES TO PROPEL MARKET
10.3 VETERINARY PATHOLOGY
10.3.1 IMPROVEMENTS IN ANIMAL DISEASE DIAGNOSTICS TO SUPPORT MARKET GROWTH
10.2 HUMAN PATHOLOGY
10.2.1 INCREASING CANCER RESEARCH ACTIVITIES TO PROPEL MARKET
10.3 VETERINARY PATHOLOGY
10.3.1 IMPROVEMENTS IN ANIMAL DISEASE DIAGNOSTICS TO SUPPORT MARKET GROWTH
11 DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY
11.1 INTRODUCTION
11.2 CONVENTIONAL DIGITAL PATHOLOGY
11.2.1 DIGITIZATION OF PATHOLOGY WORKFLOWS AND ADOPTION OF WHOLE-SLIDE IMAGING TECHNOLOGIES DRIVES MARKET
11.3 AI-ENABLED DIGITAL PATHOLOGY
11.3.1 ADOPTION OF AI AND COMPUTATIONAL PATHOLOGY TECHNOLOGIES ACCELERATES TRANSITION TO DATA-DRIVEN DIAGNOSTICS
11.2 CONVENTIONAL DIGITAL PATHOLOGY
11.2.1 DIGITIZATION OF PATHOLOGY WORKFLOWS AND ADOPTION OF WHOLE-SLIDE IMAGING TECHNOLOGIES DRIVES MARKET
11.3 AI-ENABLED DIGITAL PATHOLOGY
11.3.1 ADOPTION OF AI AND COMPUTATIONAL PATHOLOGY TECHNOLOGIES ACCELERATES TRANSITION TO DATA-DRIVEN DIAGNOSTICS
12 DIGITAL PATHOLOGY MARKET, BY APPLICATION
12.1 INTRODUCTION
12.2 CLINICAL DIAGNOSTICS
12.2.1 INCREASING CANCER INCIDENCE & GROWING ADOPTION OF AI-FOR ASSISTED DIAGNOSTICS TO DRIVE MARKET
12.3 PRE-CLINICAL RESEARCH
12.3.1 GROWTH SUPPORTED BY EXPANDING PHARMACEUTICAL AND BIOTECHNOLOGY R&D INVESTMENTS
12.3.2 DRUG DISCOVERY & EFFICACY STUDIES
12.3.2.1 Growing pharmaceutical R&D investments and rising demand for accelerated therapeutic development
12.3.3 TOXICOLOGY AND SAFETY ASSESSMENT
12.3.3.1 Increasing regulatory testing requirements and adoption of AI-enabled pathology analysis for standardized safety evaluations to drive market
12.3.4 BIOMARKER DISCOVERY & VALIDATION
12.3.4.1 Increasing adoption of personalized medicine to boost market
12.3.5 OTHER PRE-CLINICAL RESEARCH
12.4 CLINICAL TRIALS
12.4.1 USE FOR CENTRALIZED REVIEW, PATIENT STRATIFICATION, AND BIOMARKER-BASED CLINICAL STUDIES
12.5 TELEPATHOLOGY
12.5.1 INCREASING DEMAND FOR REMOTE DIAGNOSTICS AND GROWING SHORTAGE OF PATHOLOGISTS WORLDWIDE TO BOOST GROWTH
12.6 ACADEMIC & TRANSLATIONAL RESEARCH
12.6.1 GROWTH SUPPORTED BY EXPANDING COMPUTATIONAL PATHOLOGY RESEARCH AND INVESTMENTS IN PRECISION MEDICINE
12.7 EDUCATION & TRAINING
12.7.1 ABILITY TO PROVIDE REAL-TIME LEARNING EXPERIENCES TO SUPPORT MARKET GROWTH
12.8 OTHER APPLICATIONS
12.2 CLINICAL DIAGNOSTICS
12.2.1 INCREASING CANCER INCIDENCE & GROWING ADOPTION OF AI-FOR ASSISTED DIAGNOSTICS TO DRIVE MARKET
12.3 PRE-CLINICAL RESEARCH
12.3.1 GROWTH SUPPORTED BY EXPANDING PHARMACEUTICAL AND BIOTECHNOLOGY R&D INVESTMENTS
12.3.2 DRUG DISCOVERY & EFFICACY STUDIES
12.3.2.1 Growing pharmaceutical R&D investments and rising demand for accelerated therapeutic development
12.3.3 TOXICOLOGY AND SAFETY ASSESSMENT
12.3.3.1 Increasing regulatory testing requirements and adoption of AI-enabled pathology analysis for standardized safety evaluations to drive market
12.3.4 BIOMARKER DISCOVERY & VALIDATION
12.3.4.1 Increasing adoption of personalized medicine to boost market
12.3.5 OTHER PRE-CLINICAL RESEARCH
12.4 CLINICAL TRIALS
12.4.1 USE FOR CENTRALIZED REVIEW, PATIENT STRATIFICATION, AND BIOMARKER-BASED CLINICAL STUDIES
12.5 TELEPATHOLOGY
12.5.1 INCREASING DEMAND FOR REMOTE DIAGNOSTICS AND GROWING SHORTAGE OF PATHOLOGISTS WORLDWIDE TO BOOST GROWTH
12.6 ACADEMIC & TRANSLATIONAL RESEARCH
12.6.1 GROWTH SUPPORTED BY EXPANDING COMPUTATIONAL PATHOLOGY RESEARCH AND INVESTMENTS IN PRECISION MEDICINE
12.7 EDUCATION & TRAINING
12.7.1 ABILITY TO PROVIDE REAL-TIME LEARNING EXPERIENCES TO SUPPORT MARKET GROWTH
12.8 OTHER APPLICATIONS
13 DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA
13.1 INTRODUCTION
13.2 ONCOLOGY
13.2.1 INCREASING ADOPTION OF PRECISION MEDICINE AND DEMAND FOR AI-ASSISTED CANCER DIAGNOSTICS TO BOOST MARKET
13.3 HEMATOLOGY
13.3.1 IMPLEMENTATION OF AI-POWERED SOLUTIONS FOR BONE MARROW AND BLOOD CELL ANALYSIS TO DRIVE MARKET
13.4 GASTROINTESTINAL DISEASE
13.4.1 GROWING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS FOR EARLY DISEASE DETECTION AND DIAGNOSIS TO DRIVE MARKET
13.5 INFECTIOUS DISEASE
13.5.1 GROWING NEED FOR RAPID AND ACCURATE TISSUE-BASED DIAGNOSTICS TO PROPEL MARKET
13.6 NEUROLOGY
13.6.1 GROWING NEED FOR RAPID AND ACCURATE TISSUE-BASED DIAGNOSTICS DRIVES GROWTH
13.7 OTHERS THERAPEUTIC AREAS
13.2 ONCOLOGY
13.2.1 INCREASING ADOPTION OF PRECISION MEDICINE AND DEMAND FOR AI-ASSISTED CANCER DIAGNOSTICS TO BOOST MARKET
13.3 HEMATOLOGY
13.3.1 IMPLEMENTATION OF AI-POWERED SOLUTIONS FOR BONE MARROW AND BLOOD CELL ANALYSIS TO DRIVE MARKET
13.4 GASTROINTESTINAL DISEASE
13.4.1 GROWING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS FOR EARLY DISEASE DETECTION AND DIAGNOSIS TO DRIVE MARKET
13.5 INFECTIOUS DISEASE
13.5.1 GROWING NEED FOR RAPID AND ACCURATE TISSUE-BASED DIAGNOSTICS TO PROPEL MARKET
13.6 NEUROLOGY
13.6.1 GROWING NEED FOR RAPID AND ACCURATE TISSUE-BASED DIAGNOSTICS DRIVES GROWTH
13.7 OTHERS THERAPEUTIC AREAS
14 DIGITAL PATHOLOGY MARKET, BY END USER
14.1 INTRODUCTION
14.2 HOSPITALS & HEALTH SYSTEMS
14.2.1 HIGH INCIDENCE OF INFECTIOUS DISEASES TO BOOST DEMAND
14.3 DIAGNOSTICS LABORATORIES & REFERENCE LABORATORIES
14.3.1 INCREASING PUBLIC & PRIVATE FUNDING INVESTMENTS TO SUPPORT MARKET GROWTH
14.4 VETERINARY LABORATORIES
14.4.1 TECHNOLOGICAL ADVANCEMENTS IN WHOLE-SLIDE IMAGING SYSTEMS AND AI-POWERED IMAGE ANALYSIS SOFTWARE SUPPORT MARKET GROWTH
14.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
14.5.1 INCREASING FOCUS ON DRUG TOXICOLOGY TESTING AND RISING NUMBER OF PRECLINICAL TRIALS TO PROPEL MARKET
14.6 CONTRACT RESEARCH ORGANIZATION
14.6.1 DEMAND FOR OUTSOURCED RESEARCH AND BIOMARKER ANALYSIS SUPPORTS ADOPTION
14.7 ACADEMIC & RESEARCH INSTITUTES
14.7.1 INCREASING PUBLIC & PRIVATE FUNDING INVESTMENTS TO SUPPORT MARKET GROWTH
14.8 OTHER END USERS
14.2 HOSPITALS & HEALTH SYSTEMS
14.2.1 HIGH INCIDENCE OF INFECTIOUS DISEASES TO BOOST DEMAND
14.3 DIAGNOSTICS LABORATORIES & REFERENCE LABORATORIES
14.3.1 INCREASING PUBLIC & PRIVATE FUNDING INVESTMENTS TO SUPPORT MARKET GROWTH
14.4 VETERINARY LABORATORIES
14.4.1 TECHNOLOGICAL ADVANCEMENTS IN WHOLE-SLIDE IMAGING SYSTEMS AND AI-POWERED IMAGE ANALYSIS SOFTWARE SUPPORT MARKET GROWTH
14.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
14.5.1 INCREASING FOCUS ON DRUG TOXICOLOGY TESTING AND RISING NUMBER OF PRECLINICAL TRIALS TO PROPEL MARKET
14.6 CONTRACT RESEARCH ORGANIZATION
14.6.1 DEMAND FOR OUTSOURCED RESEARCH AND BIOMARKER ANALYSIS SUPPORTS ADOPTION
14.7 ACADEMIC & RESEARCH INSTITUTES
14.7.1 INCREASING PUBLIC & PRIVATE FUNDING INVESTMENTS TO SUPPORT MARKET GROWTH
14.8 OTHER END USERS
15 DIGITAL PATHOLOGY MARKET, BY REGION
15.1 INTRODUCTION
15.2 NORTH AMERICA
15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
15.2.2 US
15.2.2.1 Favorable reimbursements for diagnostics to drive market
15.2.3 CANADA
15.2.3.1 Growing awareness on early cancer detection & diagnosis to drive market
15.3 EUROPE
15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
15.3.2 GERMANY
15.3.2.1 High healthcare expenditure and supportive research initiatives to drive market
15.3.3 UK
15.3.3.1 Government funding investments for pathology services to fuel market
15.3.4 FRANCE
15.3.4.1 Increasing government funding and favorable insurance system to drive adoption
15.3.5 ITALY
15.3.5.1 Integration of AI & ML to support market growth
15.3.6 SPAIN
15.3.6.1 Supportive collaborations among leading companies and hospitals to boost demand
15.3.7 SWEDEN
15.3.7.1 Increasing prevalence of chronic diseases to support market growth
15.3.8 REST OF EUROPE
15.4 ASIA PACIFIC
15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
15.4.2 CHINA
15.4.2.1 Increasing establishment of hospitals and reference laboratories to drive market
15.4.3 JAPAN
15.4.3.1 Advanced healthcare infrastructure to support market growth
15.4.4 INDIA
15.4.4.1 High cancer incidence and rapid healthcare digitization supporting strong growth in digital pathology solutions
15.4.5 AUSTRALIA
15.4.5.1 National digital health initiatives and geographically distributed healthcare networks driving demand
15.4.6 SOUTH KOREA
15.4.6.1 Regional leadership in digital pathology and AI diagnostics supporting market expansion
15.4.7 REST OF ASIA PACIFIC
15.5 LATIN AMERICA
15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
15.5.2 BRAZIL
15.5.2.1 Biopharma clinical trial demand and Conecte SUS integration catalyzing digital pathology infrastructure
15.5.3 MEXICO
15.5.3.1 Private sector healthcare expansion and pharmaceutical manufacturing drive digital pathology adoption
15.5.4 REST OF LATIN AMERICA
15.6 MIDDLE EAST & AFRICA
15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
15.6.2 GCC COUNTRIES
15.6.2.1 Saudi Arabia
15.6.2.1.1 Vision 2030 health transformation and AI national strategy anchoring pathology digitization investment
15.6.2.2 UAE
15.6.2.2.1 National AI Strategy 2031 and DHA Digital Health Ecosystem positions country as regional pathology hub
15.6.2.3 Other GCC countries
15.6.3 SOUTH AFRICA
15.6.3.1 Growing demand for diagnostic efficiency and healthcare digitalization initiatives to boost market
15.6.4 REST OF MIDDLE EAST & AFRICA
15.2 NORTH AMERICA
15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
15.2.2 US
15.2.2.1 Favorable reimbursements for diagnostics to drive market
15.2.3 CANADA
15.2.3.1 Growing awareness on early cancer detection & diagnosis to drive market
15.3 EUROPE
15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
15.3.2 GERMANY
15.3.2.1 High healthcare expenditure and supportive research initiatives to drive market
15.3.3 UK
15.3.3.1 Government funding investments for pathology services to fuel market
15.3.4 FRANCE
15.3.4.1 Increasing government funding and favorable insurance system to drive adoption
15.3.5 ITALY
15.3.5.1 Integration of AI & ML to support market growth
15.3.6 SPAIN
15.3.6.1 Supportive collaborations among leading companies and hospitals to boost demand
15.3.7 SWEDEN
15.3.7.1 Increasing prevalence of chronic diseases to support market growth
15.3.8 REST OF EUROPE
15.4 ASIA PACIFIC
15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
15.4.2 CHINA
15.4.2.1 Increasing establishment of hospitals and reference laboratories to drive market
15.4.3 JAPAN
15.4.3.1 Advanced healthcare infrastructure to support market growth
15.4.4 INDIA
15.4.4.1 High cancer incidence and rapid healthcare digitization supporting strong growth in digital pathology solutions
15.4.5 AUSTRALIA
15.4.5.1 National digital health initiatives and geographically distributed healthcare networks driving demand
15.4.6 SOUTH KOREA
15.4.6.1 Regional leadership in digital pathology and AI diagnostics supporting market expansion
15.4.7 REST OF ASIA PACIFIC
15.5 LATIN AMERICA
15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
15.5.2 BRAZIL
15.5.2.1 Biopharma clinical trial demand and Conecte SUS integration catalyzing digital pathology infrastructure
15.5.3 MEXICO
15.5.3.1 Private sector healthcare expansion and pharmaceutical manufacturing drive digital pathology adoption
15.5.4 REST OF LATIN AMERICA
15.6 MIDDLE EAST & AFRICA
15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
15.6.2 GCC COUNTRIES
15.6.2.1 Saudi Arabia
15.6.2.1.1 Vision 2030 health transformation and AI national strategy anchoring pathology digitization investment
15.6.2.2 UAE
15.6.2.2.1 National AI Strategy 2031 and DHA Digital Health Ecosystem positions country as regional pathology hub
15.6.2.3 Other GCC countries
15.6.3 SOUTH AFRICA
15.6.3.1 Growing demand for diagnostic efficiency and healthcare digitalization initiatives to boost market
15.6.4 REST OF MIDDLE EAST & AFRICA
16 COMPETITIVE LANDSCAPE
16.1 OVERVIEW
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023-2026
16.3 REVENUE ANALYSIS, 2021-2025
16.4 MARKET SHARE ANALYSIS, 2025
16.5 BRAND COMPARISON
16.6 COMPANY VALUATION AND FINANCIAL METRICS
16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
16.7.1 STARS
16.7.2 EMERGING LEADERS
16.7.3 PERVASIVE PLAYERS
16.7.4 PARTICIPANTS
16.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
16.7.5.1 Company footprint
16.7.5.2 Region footprint
16.7.5.3 Product footprint
16.7.5.4 Application footprint
16.7.5.5 End user footprint
16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
16.8.1 PROGRESSIVE COMPANIES
16.8.2 RESPONSIVE COMPANIES
16.8.3 DYNAMIC COMPANIES
16.8.4 STARTING BLOCKS
16.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
16.8.5.1 List of startups/SMES
16.9 COMPETITIVE SCENARIO
16.9.1 PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS
16.9.2 DEALS
16.9.3 EXPANSIONS
16.9.4 OTHER DEVELOPMENTS
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023-2026
16.3 REVENUE ANALYSIS, 2021-2025
16.4 MARKET SHARE ANALYSIS, 2025
16.5 BRAND COMPARISON
16.6 COMPANY VALUATION AND FINANCIAL METRICS
16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
16.7.1 STARS
16.7.2 EMERGING LEADERS
16.7.3 PERVASIVE PLAYERS
16.7.4 PARTICIPANTS
16.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
16.7.5.1 Company footprint
16.7.5.2 Region footprint
16.7.5.3 Product footprint
16.7.5.4 Application footprint
16.7.5.5 End user footprint
16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
16.8.1 PROGRESSIVE COMPANIES
16.8.2 RESPONSIVE COMPANIES
16.8.3 DYNAMIC COMPANIES
16.8.4 STARTING BLOCKS
16.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
16.8.5.1 List of startups/SMES
16.9 COMPETITIVE SCENARIO
16.9.1 PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS
16.9.2 DEALS
16.9.3 EXPANSIONS
16.9.4 OTHER DEVELOPMENTS
17 COMPANY PROFILES
17.1 KEY COMPANIES
17.1.1 DANAHER CORPORATION
17.1.1.1 Business overview
17.1.1.2 Products offered
17.1.1.3 Recent developments
17.1.1.3.1 Product launches & enhancements
17.1.1.3.2 Deals
17.1.1.3.3 Other developments
17.1.1.4 The Analyst's View
17.1.1.4.1 Key strengths
17.1.1.4.2 Strategic choices
17.1.1.4.3 Weaknesses and competitive threats
17.1.2 HOFFMANN-LA ROCHE LTD.
17.1.2.1 Business overview
17.1.2.2 Products offered
17.1.2.3 Recent developments
17.1.2.3.1 Product launches & approvals
17.1.2.3.2 Deals
17.1.2.4 The Analyst's View
17.1.2.4.1 Key strengths
17.1.2.4.2 Strategic choices
17.1.2.4.3 Weaknesses and competitive threats
17.1.3 KONINKLIJKE PHILIPS N.V.
17.1.3.1 Business overview
17.1.3.2 Products offered
17.1.3.3 Recent developments
17.1.3.3.1 Product launches & approvals
17.1.3.3.2 Deals
17.1.3.4 The Analyst's View
17.1.3.4.1 Key strengths
17.1.3.4.2 Strategic choices
17.1.3.4.3 Weaknesses and competitive threats
17.1.4 SECTRA AB
17.1.4.1 Business overview
17.1.4.2 Products offered
17.1.4.3 Recent developments
17.1.4.3.1 Deals
17.1.4.3.2 Other developments
17.1.4.4 The Analyst's View
17.1.4.4.1 Key strengths
17.1.4.4.2 Strategic choices
17.1.4.4.3 Weaknesses and competitive threats
17.1.5 HAMAMATSU PHOTONICS K.K.
17.1.5.1 Business overview
17.1.5.2 Products offered
17.1.5.3 Recent developments
17.1.5.3.1 Deals
17.1.5.4 The Analyst's View
17.1.5.4.1 Key strengths
17.1.5.4.2 Strategic choices
17.1.5.4.3 Weaknesses and competitive threats
17.1.6 QUANTERIX CORPORATION
17.1.6.1 Business overview
17.1.6.2 Products offered
17.1.6.3 Recent developments
17.1.6.3.1 Product launches
17.1.6.4 Recent developments
17.1.6.4.1 Deals
17.1.7 FUJIFILM HOLDINGS CORPORATION
17.1.7.1 Business overview
17.1.7.2 Products offered
17.1.7.3 Recent developments
17.1.7.3.1 Deals
17.1.8 HOLOGIC, INC.
17.1.8.1 Business overview
17.1.8.2 Products offered
17.1.8.3 Recent developments
17.1.8.3.1 Product approvals
17.1.9 3DHISTECH LTD.
17.1.9.1 Business overview
17.1.9.2 Products offered
17.1.9.3 Recent developments
17.1.9.3.1 Product launches & enhancements
17.1.9.3.2 Other developments
17.1.10 APOLLO ENTERPRISE IMAGING CORP.
17.1.10.1 Business overview
17.1.10.2 Products offered
17.1.10.3 Recent developments
17.1.10.3.1 Product enhancements
17.1.10.3.2 Deals
17.1.11 HURON TECHNOLOGIES INTERNATIONAL INC.
17.1.11.1 Business overview
17.1.11.2 Products offered
17.1.11.2.1 Deals
17.1.12 INDICA LABS, LLC.
17.1.12.1 Business overview
17.1.12.2 Products offered
17.1.12.3 Recent developments
17.1.12.3.1 Product launches & approvals
17.1.12.3.2 Deals
17.1.13 OPTRASCAN
17.1.13.1 Business overview
17.1.13.2 Products offered
17.1.13.3 Recent developments
17.1.13.3.1 Product launches & approvals
17.1.13.3.2 Deals
17.1.14 GLENCOE SOFTWARE, INC.
17.1.14.1 Business overview
17.1.14.2 Products offered
17.1.14.3 Recent developments
17.1.14.3.1 Product enhancements
17.1.15 AIFORIA
17.1.15.1 Business overview
17.1.15.2 Products offered
17.1.15.3 Recent developments
17.1.15.3.1 Product launches
17.1.15.3.2 Deals
17.1.15.3.3 Expansions
17.1.16 PAIGE AI, INC.
17.1.16.1 Business overview
17.1.16.2 Products offered
17.1.16.3 Recent developments
17.1.16.3.1 Product launches & enhancements
17.1.16.3.2 Deals
17.1.17 PROSCIA INC.
17.1.17.1 Business overview
17.1.17.2 Products offered
17.1.17.3 Recent developments
17.1.17.3.1 Product enhancements & approvals
17.1.17.3.2 Deals
17.1.17.3.3 Other developments
17.1.18 EVIDENT
17.1.18.1 Business overview
17.1.18.2 Products offered
17.1.18.3 Recent developments
17.1.18.3.1 Product launches
17.1.18.3.2 Deals
17.2 OTHER PLAYERS
17.2.1 PATHAI, INC.
17.2.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD.
17.2.3 MIKROSCAN TECHNOLOGIES, INC.
17.2.4 MOTIC DIGITAL PATHOLOGY
17.2.5 MORPHLE LABS INC.
17.2.6 GRUNDIUM OY
17.2.7 CURIOSIS INC.
17.1.1 DANAHER CORPORATION
17.1.1.1 Business overview
17.1.1.2 Products offered
17.1.1.3 Recent developments
17.1.1.3.1 Product launches & enhancements
17.1.1.3.2 Deals
17.1.1.3.3 Other developments
17.1.1.4 The Analyst's View
17.1.1.4.1 Key strengths
17.1.1.4.2 Strategic choices
17.1.1.4.3 Weaknesses and competitive threats
17.1.2 HOFFMANN-LA ROCHE LTD.
17.1.2.1 Business overview
17.1.2.2 Products offered
17.1.2.3 Recent developments
17.1.2.3.1 Product launches & approvals
17.1.2.3.2 Deals
17.1.2.4 The Analyst's View
17.1.2.4.1 Key strengths
17.1.2.4.2 Strategic choices
17.1.2.4.3 Weaknesses and competitive threats
17.1.3 KONINKLIJKE PHILIPS N.V.
17.1.3.1 Business overview
17.1.3.2 Products offered
17.1.3.3 Recent developments
17.1.3.3.1 Product launches & approvals
17.1.3.3.2 Deals
17.1.3.4 The Analyst's View
17.1.3.4.1 Key strengths
17.1.3.4.2 Strategic choices
17.1.3.4.3 Weaknesses and competitive threats
17.1.4 SECTRA AB
17.1.4.1 Business overview
17.1.4.2 Products offered
17.1.4.3 Recent developments
17.1.4.3.1 Deals
17.1.4.3.2 Other developments
17.1.4.4 The Analyst's View
17.1.4.4.1 Key strengths
17.1.4.4.2 Strategic choices
17.1.4.4.3 Weaknesses and competitive threats
17.1.5 HAMAMATSU PHOTONICS K.K.
17.1.5.1 Business overview
17.1.5.2 Products offered
17.1.5.3 Recent developments
17.1.5.3.1 Deals
17.1.5.4 The Analyst's View
17.1.5.4.1 Key strengths
17.1.5.4.2 Strategic choices
17.1.5.4.3 Weaknesses and competitive threats
17.1.6 QUANTERIX CORPORATION
17.1.6.1 Business overview
17.1.6.2 Products offered
17.1.6.3 Recent developments
17.1.6.3.1 Product launches
17.1.6.4 Recent developments
17.1.6.4.1 Deals
17.1.7 FUJIFILM HOLDINGS CORPORATION
17.1.7.1 Business overview
17.1.7.2 Products offered
17.1.7.3 Recent developments
17.1.7.3.1 Deals
17.1.8 HOLOGIC, INC.
17.1.8.1 Business overview
17.1.8.2 Products offered
17.1.8.3 Recent developments
17.1.8.3.1 Product approvals
17.1.9 3DHISTECH LTD.
17.1.9.1 Business overview
17.1.9.2 Products offered
17.1.9.3 Recent developments
17.1.9.3.1 Product launches & enhancements
17.1.9.3.2 Other developments
17.1.10 APOLLO ENTERPRISE IMAGING CORP.
17.1.10.1 Business overview
17.1.10.2 Products offered
17.1.10.3 Recent developments
17.1.10.3.1 Product enhancements
17.1.10.3.2 Deals
17.1.11 HURON TECHNOLOGIES INTERNATIONAL INC.
17.1.11.1 Business overview
17.1.11.2 Products offered
17.1.11.2.1 Deals
17.1.12 INDICA LABS, LLC.
17.1.12.1 Business overview
17.1.12.2 Products offered
17.1.12.3 Recent developments
17.1.12.3.1 Product launches & approvals
17.1.12.3.2 Deals
17.1.13 OPTRASCAN
17.1.13.1 Business overview
17.1.13.2 Products offered
17.1.13.3 Recent developments
17.1.13.3.1 Product launches & approvals
17.1.13.3.2 Deals
17.1.14 GLENCOE SOFTWARE, INC.
17.1.14.1 Business overview
17.1.14.2 Products offered
17.1.14.3 Recent developments
17.1.14.3.1 Product enhancements
17.1.15 AIFORIA
17.1.15.1 Business overview
17.1.15.2 Products offered
17.1.15.3 Recent developments
17.1.15.3.1 Product launches
17.1.15.3.2 Deals
17.1.15.3.3 Expansions
17.1.16 PAIGE AI, INC.
17.1.16.1 Business overview
17.1.16.2 Products offered
17.1.16.3 Recent developments
17.1.16.3.1 Product launches & enhancements
17.1.16.3.2 Deals
17.1.17 PROSCIA INC.
17.1.17.1 Business overview
17.1.17.2 Products offered
17.1.17.3 Recent developments
17.1.17.3.1 Product enhancements & approvals
17.1.17.3.2 Deals
17.1.17.3.3 Other developments
17.1.18 EVIDENT
17.1.18.1 Business overview
17.1.18.2 Products offered
17.1.18.3 Recent developments
17.1.18.3.1 Product launches
17.1.18.3.2 Deals
17.2 OTHER PLAYERS
17.2.1 PATHAI, INC.
17.2.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD.
17.2.3 MIKROSCAN TECHNOLOGIES, INC.
17.2.4 MOTIC DIGITAL PATHOLOGY
17.2.5 MORPHLE LABS INC.
17.2.6 GRUNDIUM OY
17.2.7 CURIOSIS INC.
18 RESEARCH METHODOLOGY
18.1 RESEARCH APPROACH
18.1.1 SECONDARY RESEARCH
18.1.1.1 Key data from secondary sources
18.1.2 PRIMARY RESEARCH
18.1.2.1 Key data from primary sources
18.1.2.2 Breakdown of primaries
18.1.2.3 Insights from primary experts
18.2 RESEARCH METHODOLOGY DESIGN
18.3 MARKET SIZE ESTIMATION
18.4 MARKET BREAKDOWN DATA TRIANGULATION
18.5 MARKET SHARE ESTIMATION
18.6 STUDY ASSUMPTIONS
18.7 RESEARCH LIMITATIONS
18.7.1 METHODOLOGY-RELATED LIMITATIONS
18.7.2 SCOPE-RELATED LIMITATIONS
18.8 RISK ASSESSMENT
18.1.1 SECONDARY RESEARCH
18.1.1.1 Key data from secondary sources
18.1.2 PRIMARY RESEARCH
18.1.2.1 Key data from primary sources
18.1.2.2 Breakdown of primaries
18.1.2.3 Insights from primary experts
18.2 RESEARCH METHODOLOGY DESIGN
18.3 MARKET SIZE ESTIMATION
18.4 MARKET BREAKDOWN DATA TRIANGULATION
18.5 MARKET SHARE ESTIMATION
18.6 STUDY ASSUMPTIONS
18.7 RESEARCH LIMITATIONS
18.7.1 METHODOLOGY-RELATED LIMITATIONS
18.7.2 SCOPE-RELATED LIMITATIONS
18.8 RISK ASSESSMENT
19 APPENDIX
19.1 DISCUSSION GUIDE
19.2 KNOWLEDGESTORE: THE SUBSCRIPTION PORTAL
19.3 CUSTOMIZATION OPTIONS
19.4 RELATED REPORTS
19.5 AUTHOR DETAILS
19.2 KNOWLEDGESTORE: THE SUBSCRIPTION PORTAL
19.3 CUSTOMIZATION OPTIONS
19.4 RELATED REPORTS
19.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 EXCHANGE RATES FOR CONVERSION TO USD
TABLE 2 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
TABLE 3 HEALTHCARE DATA BREACHES: ENTITIES, IMPACT, AND CAUSES (2025)
TABLE 4 DIGITAL PATHOLOGY MARKET: PORTER’S FIVE FORCES
TABLE 5 DIGITAL PATHOLOGY MARKET: ROLE IN ECOSYSTEM
TABLE 6 INDICATIVE PRICING OF DIGITAL PATHOLOGY PRODUCTS, BY KEY PLAYER (2025)
TABLE 7 INDICATIVE PRICING OF WHOLE SLIDE IMAGING SCANNERS, BY REGION (2025)
TABLE 8 IMPORT DATA FOR HS CODE 901180, BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 9 EXPORT DATA FOR HS CODE 901180, BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 10 DIGITAL PATHOLOGY: KEY CONFERENCES & EVENTS, 2026-2027
TABLE 11 CASE 1: ASSESSING IMAGE QUALITY: A COMPARATIVE MULTI-ASSESSMENT EVALUATION OF APERIO GT 450 DX
TABLE 12 CASE STUDY 2: HOW TO PROMOTE PATHOLOGY WORKFLOW EFFICIENCY
TABLE 13 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 14 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR DIGITAL PATHOLOGY MARKET
TABLE 15 DIGITAL PATHOLOGY MARKET: KEY PATENTS/PATENT APPLICATIONS
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 REGULATORY SCENARIO IN NORTH AMERICA
TABLE 22 REGULATORY SCENARIO IN EUROPE
TABLE 23 REGULATORY SCENARIO IN ASIA PACIFIC
TABLE 24 REGULATORY SCENARIO IN LATIN AMERICA
TABLE 25 REGULATORY SCENARIO IN MIDDLE EAST & AFRICA
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
TABLE 27 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 28 UNMET NEEDS IN DIGITAL PATHOLOGY MARKET
TABLE 29 END USER EXPECTATIONS IN DIGITAL PATHOLOGY MARKET
TABLE 30 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 31 DIGITAL PATHOLOGY HARDWARE OFFERED BY KEY MARKET PLAYERS
TABLE 32 DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 33 DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY REGION, 2024-2031(USD MILLION)
TABLE 34 SCANNING MAGNIFICATION AND APPLICATIONS
TABLE 35 DIGITAL PATHOLOGY WHOLE SLIDE IMAGING (WSI) SCANNERS OFFERED BY KEY MARKET PLAYERS
TABLE 36 DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 37 DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 38 BRIGHTFIELD SCANNERS OFFERED BY KEY MARKET PLAYERS
TABLE 39 DIGITAL PATHOLOGY MARKET FOR BRIGHTFIELD SCANNERS, BY REGION, 2024-2031(USD MILLION)
TABLE 40 FLUORESCENCE SCANNERS OFFERED BY KEY MARKET PLAYERS
TABLE 41 DIGITAL PATHOLOGY MARKET FOR FLUORESCENCE SCANNERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 42 OTHER SCANNERS OFFERED BY KEY MARKET PLAYERS
TABLE 43 DIGITAL PATHOLOGY MARKET FOR OTHER SCANNERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 44 WORKSTATIONS & VIEWING SYSTEMS: OFFERED BY KEY MARKET PLAYERS
TABLE 45 DIGITAL PATHOLOGY MARKET FOR WORKSTATIONS & VIEWING SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
TABLE 46 PERIPHERALS & ACCESSORIES OFFERED BY KEY MARKET PLAYERS
TABLE 47 DIGITAL PATHOLOGY MARKET FOR PERIPHERALS & ACCESSORIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 48 DIGITAL PATHOLOGY SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 49 DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 50 DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY REGION, 2024-2031 (USD MILLION)
TABLE 51 ENTERPRISE DIGITAL PATHOLOGY SOLUTIONS/PLATFORMS OFFERED BY KEY MARKET PLAYERS
TABLE 52 DIGITAL PATHOLOGY MARKET FOR ENTERPRISE DIGITAL PATHOLOGY SOLUTIONS/PLATFORMS, BY REGION, 2024-2031 (USD MILLION)
TABLE 53 IMAGE MANAGEMENT SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 54 DIGITAL PATHOLOGY MARKET FOR IMAGE MANAGEMENT SOFTWARE, BY REGION, 2024-2031 (USD MILLION)
TABLE 55 IMAGE ANALYSIS SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 56 DIGITAL PATHOLOGY MARKET FOR IMAGE ANALYSIS SOFTWARE, BY REGION, 2024-2031 (USD MILLION)
TABLE 57 AI & COMPUTATIONAL PATHOLOGY SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 58 DIGITAL PATHOLOGY MARKET FOR AI & COMPUTATIONAL PATHOLOGY SOFTWARE, BY REGION, 2024-2031 (USD MILLION)
TABLE 59 DIGITAL PATHOLOGY STORAGE SYSTEMS OFFERED BY KEY MARKET PLAYERS
TABLE 60 DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 61 DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
TABLE 62 DIGITAL PATHOLOGY MARKET FOR ON-PREMISE STORAGE, BY REGION, 2024-2031 (USD MILLION)
TABLE 63 DIGITAL PATHOLOGY MARKET FOR CLOUD STORAGE, BY REGION, 2024-2031 (USD MILLION)
TABLE 64 DIGITAL PATHOLOGY MARKET FOR HYBRID STORAGE, BY REGION, 2024-2031 (USD MILLION)
TABLE 65 DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 66 DIGITAL PATHOLOGY MARKET FOR HUMAN DIGITAL PATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 67 DIGITAL PATHOLOGY MARKET FOR VETERINARY DIGITAL PATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 68 DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 69 DIGITAL PATHOLOGY MARKET FOR CONVENTIONAL DIGITAL PATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 70 DIGITAL PATHOLOGY MARKET FOR AI-ENABLED DIGITAL PATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 71 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 72 DIGITAL PATHOLOGY MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2024-2031 (USD MILLION)
TABLE 73 DIGITAL PATHOLOGY MARKET, BY PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 74 DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY REGION, 2024-2031 (USD MILLION)
TABLE 75 DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY & EFFICACY STUDIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 76 DIGITAL PATHOLOGY MARKET FOR TOXICOLOGY AND SAFETY ASSESSMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 77 DIGITAL PATHOLOGY MARKET FOR BIOMARKER DISCOVERY AND VALIDATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 78 DIGITAL PATHOLOGY MARKET OTHER PRE-CLINICAL RESEARCH, BY REGION, 2024-2031 (USD MILLION)
TABLE 79 DIGITAL PATHOLOGY MARKET FOR CLINICAL TRIALS, BY REGION, 2024-2031 (USD MILLION)
TABLE 80 DIGITAL PATHOLOGY MARKET FOR TELEPATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 81 DIGITAL PATHOLOGY MARKET FOR ACADEMIC & TRANSLATIONAL RESEARCH, BY REGION, 2024-2031 (USD MILLION)
TABLE 82 DIGITAL PATHOLOGY MARKET FOR EDUCATION & TRAINING, BY REGION, 2024-2031 (USD MILLION)
TABLE 83 DIGITAL PATHOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 84 DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 85 DIGITAL PATHOLOGY MARKET FOR ONCOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 86 DIGITAL PATHOLOGY MARKET FOR HEMATOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 87 DIGITAL PATHOLOGY MARKET FOR GASTROINTESTINAL DISEASE, BY REGION, 2024-2031 (USD MILLION)
TABLE 88 DIGITAL PATHOLOGY MARKET FOR INFECTIOUS DISEASE, BY REGION, 2024-2031 (USD MILLION)
TABLE 89 DIGITAL PATHOLOGY MARKET FOR NEUROLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 90 DIGITAL PATHOLOGY MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2024-2031 (USD MILLION)
TABLE 91 DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 92 DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS IN HOSPITALS & HEALTH SYSTEMS
TABLE 93 DIGITAL PATHOLOGY MARKET FOR HOSPITALS & HEALTH SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
TABLE 94 DIGITAL PATHOLOGY MARKET FOR DIAGNOSTICS & REFERENCE LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 95 DIGITAL PATHOLOGY MARKET FOR VETERINARY LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 96 DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 97 DIGITAL PATHOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 98 DIGITAL PATHOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
TABLE 99 DIGITAL PATHOLOGY MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 100 DIGITAL PATHOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 101 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 102 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 103 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 104 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 105 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031(USD MILLION)
TABLE 106 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031(USD MILLION)
TABLE 107 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 108 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 109 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 110 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 111 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 112 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 113 CAT III - DIGITAL PATHOLOGY ADD-ON CPT CODES - EFFECTIVE 1 JANUARY 2024
TABLE 114 US: CANCER INCIDENCE, BY CANCER TYPE, 2022 VS. 2040
TABLE 115 US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 116 US: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 117 US: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 118 US: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031(USD MILLION)
TABLE 119 US: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031(USD MILLION)
TABLE 120 US: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 121 US: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 122 US: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 123 US: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 124 US: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 125 US: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 126 CANADA: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 127 CANADA: FUNDING INITIATIVES FOR DIGITAL PATHOLOGY
TABLE 128 CANADA: KEY MACROINDICATORS
TABLE 129 CANADA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 130 CANADA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 131 CANADA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 132 CANADA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031(USD MILLION)
TABLE 133 CANADA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031(USD MILLION)
TABLE 134 CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 135 CANADA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 136 CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 137 CANADA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 138 CANADA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 139 CANADA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 140 EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 141 EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 142 EUROPE: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 143 EUROPE: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 144 EUROPE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 145 EUROPE: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 146 EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 147 EUROPE: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 148 EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 149 EUROPE: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 150 EUROPE: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 151 EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 152 GERMANY: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 153 GERMANY: KEY MACROINDICATORS
TABLE 154 GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 155 GERMANY: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 156 GERMANY: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 157 GERMANY: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 158 GERMANY: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 159 GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 160 GERMANY: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 161 GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 162 GERMANY: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 163 GERMANY: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 164 GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 165 UK: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 166 UK: KEY MACROINDICATORS
TABLE 167 UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 168 UK: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 169 UK: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 170 UK: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 171 UK: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 172 UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 173 UK: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 174 UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 175 UK: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 176 UK: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 177 UK: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 178 FRANCE: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 179 FRANCE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 180 FRANCE: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 181 FRANCE: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 182 FRANCE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 183 FRANCE: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 184 FRANCE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 185 FRANCE: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 186 FRANCE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 187 FRANCE: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 188 FRANCE: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 189 FRANCE: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 190 ITALY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 191 ITALY: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 192 ITALY: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 193 ITALY: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 194 ITALY: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 195 ITALY: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 196 ITALY: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 197 ITALY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 198 ITALY: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 199 ITALY: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 200 ITALY: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 201 SPAIN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 202 SPAIN: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 203 SPAIN: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 204 SPAIN: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 205 SPAIN: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 206 SPAIN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 207 SPAIN: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 208 SPAIN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 209 SPAIN: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 210 SPAIN: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 211 SPAIN: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 212 SWEDEN: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 213 SWEDEN: KEY MACROINDICATORS
TABLE 214 SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 215 SWEDEN: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 216 SWEDEN: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 217 SWEDEN: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 218 SWEDEN: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 219 SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 220 SWEDEN: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 221 SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 222 SWEDEN: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 223 SWEDEN: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 224 SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 225 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 226 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 227 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 228 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 229 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 230 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 231 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 232 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 233 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 234 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 235 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 236 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 237 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 238 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 239 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 240 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 241 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 242 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 243 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 244 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 245 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 246 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 247 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 248 CHINA: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 249 CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 250 CHINA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 251 CHINA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 252 CHINA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 253 CHINA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 254 CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 255 CHINA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 256 CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 257 CHINA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 258 CHINA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 259 CHINA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 260 JAPAN: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 261 JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 262 JAPAN: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 263 JAPAN: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 264 JAPAN: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 265 JAPAN: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 266 JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 267 JAPAN: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 268 JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 269 JAPAN: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 270 JAPAN: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 271 JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 272 INDIA: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 273 INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 274 INDIA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 275 INDIA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 276 INDIA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 277 INDIA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 278 INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 279 INDIA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 280 INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 281 INDIA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 282 INDIA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 283 INDIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 284 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 285 AUSTRALIA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 286 AUSTRALIA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 287 AUSTRALIA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 288 AUSTRALIA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 289 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 290 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 291 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 292 AUSTRALIA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 293 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 294 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 295 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 296 SOUTH KOREA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 297 SOUTH KOREA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 298 SOUTH KOREA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 299 SOUTH KOREA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 300 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 301 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 302 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 303 SOUTH KOREA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 304 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 305 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 306 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 307 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 308 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 309 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 310 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 311 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 312 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 313 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 314 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 315 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 316 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 317 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 318 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 319 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 320 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 321 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 322 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 323 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 324 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 325 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 326 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 327 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 328 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 329 BRAZIL: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 330 BRAZIL: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 331 BRAZIL: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 332 BRAZIL: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 333 BRAZIL: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 334 BRAZIL: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 335 BRAZIL: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 336 BRAZIL: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 337 BRAZIL: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 338 BRAZIL: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 339 BRAZIL: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 340 BRAZIL: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 341 MEXICO: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 342 MEXICO: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 343 MEXICO: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 344 MEXICO: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 345 MEXICO: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 346 MEXICO: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 347 MEXICO: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 348 MEXICO: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 349 MEXICO: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 350 MEXICO: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 351 MEXICO: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 352 MEXICO: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 353 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 354 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 355 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 356 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 357 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 358 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 359 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 360 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 361 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 362 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 363 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 364 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 365 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 366 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 367 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 368 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 369 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 370 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 371 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 372 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 373 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 374 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 375 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 376 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 377 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 378 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 379 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 380 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 381 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 382 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 383 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 384 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 385 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 386 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 387 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 388 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 389 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 390 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 391 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 392 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 393 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 394 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 395 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 396 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 397 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 398 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 399 UAE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 400 UAE: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 401 UAE: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 402 UAE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 403 UAE: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 404 UAE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 405 UAE: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 406 UAE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 407 UAE: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 408 UAE: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 409 UAE: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 410 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 411 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 412 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 413 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 414 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 415 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 416 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 417 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 418 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 419 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 420 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 421 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 422 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 423 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 424 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 425 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 426 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 427 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 428 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 429 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 430 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 431 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 432 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 433 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 434 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 435 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 436 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 437 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 438 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 439 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 440 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 441 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 442 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 443 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023-2026
TABLE 444 DIGITAL PATHOLOGY MARKET: DEGREE OF COMPETITION
TABLE 445 DIGITAL PATHOLOGY MARKET: REGION FOOTPRINT
TABLE 446 DIGITAL PATHOLOGY MARKET: PRODUCT FOOTPRINT
TABLE 447 DIGITAL PATHOLOGY MARKET: APPLICATION FOOTPRINT
TABLE 448 DIGITAL PATHOLOGY MARKET: END USER FOOTPRINT
TABLE 449 LIST OF STARTUPS/SMES
TABLE 450 DIGITAL PATHOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 451 DIGITAL PATHOLOGY MARKET: PRODUCT LAUNCHES, ENHANCEMENTS, APPROVALS 2023-2026
TABLE 452 DIGITAL PATHOLOGY MARKET: DEALS, 2023-2026
TABLE 453 DIGITAL PATHOLOGY MARKET: EXPANSIONS, 2023-2026
TABLE 454 DIGITAL PATHOLOGY MARKET: OTHER DEVELOPMENTS, 2023-2026
TABLE 455 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 456 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 457 DANAHER CORPORATION: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2023-JUNE 2026
TABLE 458 DANAHER CORPORATION: DEALS, JANUARY 2023-JUNE 2026
TABLE 459 DANAHER CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
TABLE 460 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 461 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 462 HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
TABLE 463 HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2023-JUNE 2026
TABLE 464 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 465 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 466 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
TABLE 467 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023-JUNE 2026
TABLE 468 SECTRA AB: COMPANY OVERVIEW
TABLE 469 SECTRA AB: PRODUCTS OFFERED
TABLE 470 SECTRA AB: DEALS, JANUARY 2023-JUNE 2026
TABLE 471 SECTRA AB: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
TABLE 472 HAMAMATSU PHOTONICS K.K.: COMPANY OVERVIEW
TABLE 473 HAMAMATSU PHOTONICS K.K.: PRODUCTS OFFERED
TABLE 474 HAMAMATSU PHOTONICS K.K.: DEALS, JANUARY 2023-JUNE 2026
TABLE 475 QUANTERIX CORPORATION: COMPANY OVERVIEW
TABLE 476 QUANTERIX CORPORATION: PRODUCTS OFFERED
TABLE 477 QUANTERIX CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026
TABLE 478 QUANTERIX CORPORATION :DEALS, JANUARY 2023-JUNE 2026
TABLE 479 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
TABLE 480 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
TABLE 481 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2023-JUNE 2026
TABLE 482 HOLOGIC, INC.: COMPANY OVERVIEW
TABLE 483 HOLOGIC, INC: PRODUCTS OFFERED
TABLE 484 HOLOGIC, INC: PRODUCT APPROVALS, JANUARY 2023-JUNE 2026
TABLE 485 3DHISTECH LTD.: COMPANY OVERVIEW
TABLE 486 3DHISTECH LTD.: PRODUCTS OFFERED
TABLE 487 3DHISTECH LTD.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2023-JUNE 2026
TABLE 488 3DHISTECH LTD.: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
TABLE 489 APOLLO ENTERPRISE IMAGING CORP.: COMPANY OVERVIEW
TABLE 490 APOLLO ENTERPRISE IMAGING CORP.: PRODUCTS OFFERED
TABLE 491 APOLLO ENTERPRISE IMAGING CORP.: PRODUCT ENHANCEMENTS, JANUARY 2023-JUNE 2026
TABLE 492 APOLLO ENTERPRISE IMAGING CORP.: DEALS, JANUARY 2023-JUNE 2026
TABLE 493 HURON TECHNOLOGIES INTERNATIONAL INC.: COMPANY OVERVIEW
TABLE 494 HURON TECHNOLOGIES INTERNATIONAL INC.: PRODUCTS OFFERED
TABLE 495 HURON TECHNOLOGIES INTERNATIONAL INC.: DEALS, JANUARY 2023-JUNE 2026
TABLE 496 HURON TECHNOLOGIES INTERNATIONAL INC.: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
TABLE 497 INDICA LABS, LLC.: COMPANY OVERVIEW
TABLE 498 INDICA LABS, LLC: PRODUCTS OFFERED
TABLE 499 INDICA LABS, LLC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
TABLE 500 INDICA LABS, LLC.: DEALS, JANUARY 2023-JUNE 2026
TABLE 501 INDICA LABS, LLC.: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
TABLE 502 OPTRASCAN: COMPANY OVERVIEW
TABLE 503 OPTRASCAN: PRODUCTS OFFERED
TABLE 504 OPTRASCAN: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
TABLE 505 OPTRASCAN: DEALS, JANUARY 2023-JUNE 2026
TABLE 506 GLENCOE SOFTWARE, INC.: COMPANY OVERVIEW
TABLE 507 GLENCOE SOFTWARE, INC.: PRODUCTS OFFERED
TABLE 508 GLENCOE SOFTWARE, INC.: PRODUCT ENHANCEMENTS, JANUARY 2023-JUNE 2026
TABLE 509 AIFORIA: COMPANY OVERVIEW
TABLE 510 AIFORIA: PRODUCTS OFFERED
TABLE 511 AIFORIA: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026
TABLE 512 AIFORIA: DEALS, JANUARY 2023-JUNE 2026
TABLE 513 AIFORIA: EXPANSIONS, JANUARY 2023-JUNE 2026
TABLE 514 PAIGE AI, INC.: COMPANY OVERVIEW
TABLE 515 PAIGE AI, INC.: PRODUCTS OFFERED
TABLE 516 PAIGE AI, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2023-JUNE 2026
TABLE 517 PAIGE AI, INC.: DEALS, JANUARY 2023-JUNE 2026
TABLE 518 PROSCIA INC.: COMPANY OVERVIEW
TABLE 519 PROSCIA INC.: PRODUCTS OFFERED
TABLE 520 PROSCIA INC.: PRODUCT ENHANCEMENTS & APPROVALS, JANUARY 2023-JUNE 2026
TABLE 521 PROSCIA INC.: DEALS, JANUARY 2023-JUNE 2026
TABLE 522 PROSCIA INC.: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
TABLE 523 EVIDENT: COMPANY OVERVIEW
TABLE 524 EVIDENT: PRODUCTS OFFERED
TABLE 525 EVIDENT: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026
TABLE 526 EVIDENT: DEALS, JANUARY 2023-JUNE 2026
TABLE 527 RISK ASSESSMENT: DIGITAL PATHOLOGY MARKET
TABLE 2 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
TABLE 3 HEALTHCARE DATA BREACHES: ENTITIES, IMPACT, AND CAUSES (2025)
TABLE 4 DIGITAL PATHOLOGY MARKET: PORTER’S FIVE FORCES
TABLE 5 DIGITAL PATHOLOGY MARKET: ROLE IN ECOSYSTEM
TABLE 6 INDICATIVE PRICING OF DIGITAL PATHOLOGY PRODUCTS, BY KEY PLAYER (2025)
TABLE 7 INDICATIVE PRICING OF WHOLE SLIDE IMAGING SCANNERS, BY REGION (2025)
TABLE 8 IMPORT DATA FOR HS CODE 901180, BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 9 EXPORT DATA FOR HS CODE 901180, BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 10 DIGITAL PATHOLOGY: KEY CONFERENCES & EVENTS, 2026-2027
TABLE 11 CASE 1: ASSESSING IMAGE QUALITY: A COMPARATIVE MULTI-ASSESSMENT EVALUATION OF APERIO GT 450 DX
TABLE 12 CASE STUDY 2: HOW TO PROMOTE PATHOLOGY WORKFLOW EFFICIENCY
TABLE 13 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 14 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR DIGITAL PATHOLOGY MARKET
TABLE 15 DIGITAL PATHOLOGY MARKET: KEY PATENTS/PATENT APPLICATIONS
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 REGULATORY SCENARIO IN NORTH AMERICA
TABLE 22 REGULATORY SCENARIO IN EUROPE
TABLE 23 REGULATORY SCENARIO IN ASIA PACIFIC
TABLE 24 REGULATORY SCENARIO IN LATIN AMERICA
TABLE 25 REGULATORY SCENARIO IN MIDDLE EAST & AFRICA
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
TABLE 27 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 28 UNMET NEEDS IN DIGITAL PATHOLOGY MARKET
TABLE 29 END USER EXPECTATIONS IN DIGITAL PATHOLOGY MARKET
TABLE 30 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 31 DIGITAL PATHOLOGY HARDWARE OFFERED BY KEY MARKET PLAYERS
TABLE 32 DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 33 DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY REGION, 2024-2031(USD MILLION)
TABLE 34 SCANNING MAGNIFICATION AND APPLICATIONS
TABLE 35 DIGITAL PATHOLOGY WHOLE SLIDE IMAGING (WSI) SCANNERS OFFERED BY KEY MARKET PLAYERS
TABLE 36 DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 37 DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 38 BRIGHTFIELD SCANNERS OFFERED BY KEY MARKET PLAYERS
TABLE 39 DIGITAL PATHOLOGY MARKET FOR BRIGHTFIELD SCANNERS, BY REGION, 2024-2031(USD MILLION)
TABLE 40 FLUORESCENCE SCANNERS OFFERED BY KEY MARKET PLAYERS
TABLE 41 DIGITAL PATHOLOGY MARKET FOR FLUORESCENCE SCANNERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 42 OTHER SCANNERS OFFERED BY KEY MARKET PLAYERS
TABLE 43 DIGITAL PATHOLOGY MARKET FOR OTHER SCANNERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 44 WORKSTATIONS & VIEWING SYSTEMS: OFFERED BY KEY MARKET PLAYERS
TABLE 45 DIGITAL PATHOLOGY MARKET FOR WORKSTATIONS & VIEWING SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
TABLE 46 PERIPHERALS & ACCESSORIES OFFERED BY KEY MARKET PLAYERS
TABLE 47 DIGITAL PATHOLOGY MARKET FOR PERIPHERALS & ACCESSORIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 48 DIGITAL PATHOLOGY SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 49 DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 50 DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY REGION, 2024-2031 (USD MILLION)
TABLE 51 ENTERPRISE DIGITAL PATHOLOGY SOLUTIONS/PLATFORMS OFFERED BY KEY MARKET PLAYERS
TABLE 52 DIGITAL PATHOLOGY MARKET FOR ENTERPRISE DIGITAL PATHOLOGY SOLUTIONS/PLATFORMS, BY REGION, 2024-2031 (USD MILLION)
TABLE 53 IMAGE MANAGEMENT SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 54 DIGITAL PATHOLOGY MARKET FOR IMAGE MANAGEMENT SOFTWARE, BY REGION, 2024-2031 (USD MILLION)
TABLE 55 IMAGE ANALYSIS SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 56 DIGITAL PATHOLOGY MARKET FOR IMAGE ANALYSIS SOFTWARE, BY REGION, 2024-2031 (USD MILLION)
TABLE 57 AI & COMPUTATIONAL PATHOLOGY SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 58 DIGITAL PATHOLOGY MARKET FOR AI & COMPUTATIONAL PATHOLOGY SOFTWARE, BY REGION, 2024-2031 (USD MILLION)
TABLE 59 DIGITAL PATHOLOGY STORAGE SYSTEMS OFFERED BY KEY MARKET PLAYERS
TABLE 60 DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 61 DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
TABLE 62 DIGITAL PATHOLOGY MARKET FOR ON-PREMISE STORAGE, BY REGION, 2024-2031 (USD MILLION)
TABLE 63 DIGITAL PATHOLOGY MARKET FOR CLOUD STORAGE, BY REGION, 2024-2031 (USD MILLION)
TABLE 64 DIGITAL PATHOLOGY MARKET FOR HYBRID STORAGE, BY REGION, 2024-2031 (USD MILLION)
TABLE 65 DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 66 DIGITAL PATHOLOGY MARKET FOR HUMAN DIGITAL PATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 67 DIGITAL PATHOLOGY MARKET FOR VETERINARY DIGITAL PATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 68 DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 69 DIGITAL PATHOLOGY MARKET FOR CONVENTIONAL DIGITAL PATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 70 DIGITAL PATHOLOGY MARKET FOR AI-ENABLED DIGITAL PATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 71 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 72 DIGITAL PATHOLOGY MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2024-2031 (USD MILLION)
TABLE 73 DIGITAL PATHOLOGY MARKET, BY PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 74 DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY REGION, 2024-2031 (USD MILLION)
TABLE 75 DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY & EFFICACY STUDIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 76 DIGITAL PATHOLOGY MARKET FOR TOXICOLOGY AND SAFETY ASSESSMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 77 DIGITAL PATHOLOGY MARKET FOR BIOMARKER DISCOVERY AND VALIDATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 78 DIGITAL PATHOLOGY MARKET OTHER PRE-CLINICAL RESEARCH, BY REGION, 2024-2031 (USD MILLION)
TABLE 79 DIGITAL PATHOLOGY MARKET FOR CLINICAL TRIALS, BY REGION, 2024-2031 (USD MILLION)
TABLE 80 DIGITAL PATHOLOGY MARKET FOR TELEPATHOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 81 DIGITAL PATHOLOGY MARKET FOR ACADEMIC & TRANSLATIONAL RESEARCH, BY REGION, 2024-2031 (USD MILLION)
TABLE 82 DIGITAL PATHOLOGY MARKET FOR EDUCATION & TRAINING, BY REGION, 2024-2031 (USD MILLION)
TABLE 83 DIGITAL PATHOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 84 DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 85 DIGITAL PATHOLOGY MARKET FOR ONCOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 86 DIGITAL PATHOLOGY MARKET FOR HEMATOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 87 DIGITAL PATHOLOGY MARKET FOR GASTROINTESTINAL DISEASE, BY REGION, 2024-2031 (USD MILLION)
TABLE 88 DIGITAL PATHOLOGY MARKET FOR INFECTIOUS DISEASE, BY REGION, 2024-2031 (USD MILLION)
TABLE 89 DIGITAL PATHOLOGY MARKET FOR NEUROLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 90 DIGITAL PATHOLOGY MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2024-2031 (USD MILLION)
TABLE 91 DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 92 DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS IN HOSPITALS & HEALTH SYSTEMS
TABLE 93 DIGITAL PATHOLOGY MARKET FOR HOSPITALS & HEALTH SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
TABLE 94 DIGITAL PATHOLOGY MARKET FOR DIAGNOSTICS & REFERENCE LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 95 DIGITAL PATHOLOGY MARKET FOR VETERINARY LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 96 DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 97 DIGITAL PATHOLOGY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 98 DIGITAL PATHOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
TABLE 99 DIGITAL PATHOLOGY MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 100 DIGITAL PATHOLOGY MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 101 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 102 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 103 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 104 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 105 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031(USD MILLION)
TABLE 106 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031(USD MILLION)
TABLE 107 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 108 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 109 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 110 NORTH AMERICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 111 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 112 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 113 CAT III - DIGITAL PATHOLOGY ADD-ON CPT CODES - EFFECTIVE 1 JANUARY 2024
TABLE 114 US: CANCER INCIDENCE, BY CANCER TYPE, 2022 VS. 2040
TABLE 115 US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 116 US: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 117 US: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 118 US: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031(USD MILLION)
TABLE 119 US: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031(USD MILLION)
TABLE 120 US: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 121 US: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 122 US: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 123 US: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 124 US: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 125 US: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 126 CANADA: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 127 CANADA: FUNDING INITIATIVES FOR DIGITAL PATHOLOGY
TABLE 128 CANADA: KEY MACROINDICATORS
TABLE 129 CANADA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 130 CANADA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 131 CANADA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 132 CANADA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031(USD MILLION)
TABLE 133 CANADA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031(USD MILLION)
TABLE 134 CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 135 CANADA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 136 CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 137 CANADA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 138 CANADA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 139 CANADA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 140 EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 141 EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 142 EUROPE: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 143 EUROPE: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 144 EUROPE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 145 EUROPE: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 146 EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 147 EUROPE: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 148 EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 149 EUROPE: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 150 EUROPE: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 151 EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 152 GERMANY: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 153 GERMANY: KEY MACROINDICATORS
TABLE 154 GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 155 GERMANY: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 156 GERMANY: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 157 GERMANY: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 158 GERMANY: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 159 GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 160 GERMANY: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 161 GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 162 GERMANY: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 163 GERMANY: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 164 GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 165 UK: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 166 UK: KEY MACROINDICATORS
TABLE 167 UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 168 UK: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 169 UK: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 170 UK: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 171 UK: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 172 UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 173 UK: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 174 UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 175 UK: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 176 UK: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 177 UK: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 178 FRANCE: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 179 FRANCE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 180 FRANCE: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 181 FRANCE: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 182 FRANCE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 183 FRANCE: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 184 FRANCE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 185 FRANCE: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 186 FRANCE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 187 FRANCE: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 188 FRANCE: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 189 FRANCE: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 190 ITALY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 191 ITALY: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 192 ITALY: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 193 ITALY: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 194 ITALY: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 195 ITALY: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 196 ITALY: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 197 ITALY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 198 ITALY: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 199 ITALY: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 200 ITALY: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 201 SPAIN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 202 SPAIN: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 203 SPAIN: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 204 SPAIN: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 205 SPAIN: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 206 SPAIN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 207 SPAIN: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 208 SPAIN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 209 SPAIN: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 210 SPAIN: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 211 SPAIN: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 212 SWEDEN: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 213 SWEDEN: KEY MACROINDICATORS
TABLE 214 SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 215 SWEDEN: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 216 SWEDEN: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 217 SWEDEN: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 218 SWEDEN: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 219 SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 220 SWEDEN: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 221 SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 222 SWEDEN: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 223 SWEDEN: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 224 SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 225 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 226 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 227 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 228 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 229 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 230 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 231 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 232 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 233 REST OF EUROPE: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 234 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 235 REST OF EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 236 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 237 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 238 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 239 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 240 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 241 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 242 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 243 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 244 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 245 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 246 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 247 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 248 CHINA: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 249 CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 250 CHINA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 251 CHINA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 252 CHINA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 253 CHINA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 254 CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 255 CHINA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 256 CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 257 CHINA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 258 CHINA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 259 CHINA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 260 JAPAN: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 261 JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 262 JAPAN: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 263 JAPAN: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 264 JAPAN: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 265 JAPAN: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 266 JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 267 JAPAN: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 268 JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 269 JAPAN: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 270 JAPAN: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 271 JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 272 INDIA: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 273 INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 274 INDIA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 275 INDIA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 276 INDIA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 277 INDIA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 278 INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 279 INDIA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 280 INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 281 INDIA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 282 INDIA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 283 INDIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 284 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 285 AUSTRALIA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 286 AUSTRALIA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 287 AUSTRALIA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 288 AUSTRALIA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 289 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 290 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 291 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 292 AUSTRALIA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 293 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 294 AUSTRALIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 295 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 296 SOUTH KOREA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 297 SOUTH KOREA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 298 SOUTH KOREA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 299 SOUTH KOREA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 300 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 301 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 302 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 303 SOUTH KOREA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 304 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 305 SOUTH KOREA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 306 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 307 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 308 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 309 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 310 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 311 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 312 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 313 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 314 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 315 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 316 REST OF ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 317 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 318 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 319 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 320 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 321 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 322 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 323 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 324 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 325 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 326 LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 327 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 328 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 329 BRAZIL: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 330 BRAZIL: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 331 BRAZIL: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 332 BRAZIL: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 333 BRAZIL: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 334 BRAZIL: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 335 BRAZIL: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 336 BRAZIL: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 337 BRAZIL: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 338 BRAZIL: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 339 BRAZIL: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 340 BRAZIL: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 341 MEXICO: CANCER INCIDENCE, BY CANCER TYPE, 2020 VS. 2040
TABLE 342 MEXICO: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 343 MEXICO: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 344 MEXICO: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 345 MEXICO: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 346 MEXICO: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 347 MEXICO: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 348 MEXICO: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 349 MEXICO: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 350 MEXICO: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 351 MEXICO: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 352 MEXICO: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 353 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 354 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 355 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 356 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 357 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 358 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 359 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 360 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 361 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 362 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 363 REST OF LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 364 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 365 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 366 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 367 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 368 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 369 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 370 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 371 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 372 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 373 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 374 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 375 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 376 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 377 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 378 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 379 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 380 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 381 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 382 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 383 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 384 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 385 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 386 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 387 GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 388 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 389 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 390 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 391 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 392 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 393 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 394 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 395 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 396 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 397 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 398 SAUDI ARABIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 399 UAE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 400 UAE: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 401 UAE: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 402 UAE: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 403 UAE: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 404 UAE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 405 UAE: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 406 UAE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 407 UAE: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 408 UAE: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 409 UAE: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 410 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 411 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 412 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 413 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 414 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 415 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 416 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 417 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 418 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 419 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 420 OTHER GCC COUNTRIES: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 421 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 422 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 423 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 424 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 425 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 426 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 427 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 428 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 429 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 430 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 431 SOUTH AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 432 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 433 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR HARDWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 434 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR WHOLE SLIDE IMAGING SCANNERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 435 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY TYPE, 2024-2031 (USD MILLION)
TABLE 436 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR STORAGE SYSTEMS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 437 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 438 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 439 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 440 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET FOR PRE-CLINICAL RESEARCH, BY TYPE, 2024-2031 (USD MILLION)
TABLE 441 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 442 REST OF MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 443 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023-2026
TABLE 444 DIGITAL PATHOLOGY MARKET: DEGREE OF COMPETITION
TABLE 445 DIGITAL PATHOLOGY MARKET: REGION FOOTPRINT
TABLE 446 DIGITAL PATHOLOGY MARKET: PRODUCT FOOTPRINT
TABLE 447 DIGITAL PATHOLOGY MARKET: APPLICATION FOOTPRINT
TABLE 448 DIGITAL PATHOLOGY MARKET: END USER FOOTPRINT
TABLE 449 LIST OF STARTUPS/SMES
TABLE 450 DIGITAL PATHOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 451 DIGITAL PATHOLOGY MARKET: PRODUCT LAUNCHES, ENHANCEMENTS, APPROVALS 2023-2026
TABLE 452 DIGITAL PATHOLOGY MARKET: DEALS, 2023-2026
TABLE 453 DIGITAL PATHOLOGY MARKET: EXPANSIONS, 2023-2026
TABLE 454 DIGITAL PATHOLOGY MARKET: OTHER DEVELOPMENTS, 2023-2026
TABLE 455 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 456 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 457 DANAHER CORPORATION: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2023-JUNE 2026
TABLE 458 DANAHER CORPORATION: DEALS, JANUARY 2023-JUNE 2026
TABLE 459 DANAHER CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
TABLE 460 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 461 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 462 HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
TABLE 463 HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2023-JUNE 2026
TABLE 464 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 465 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 466 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
TABLE 467 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023-JUNE 2026
TABLE 468 SECTRA AB: COMPANY OVERVIEW
TABLE 469 SECTRA AB: PRODUCTS OFFERED
TABLE 470 SECTRA AB: DEALS, JANUARY 2023-JUNE 2026
TABLE 471 SECTRA AB: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
TABLE 472 HAMAMATSU PHOTONICS K.K.: COMPANY OVERVIEW
TABLE 473 HAMAMATSU PHOTONICS K.K.: PRODUCTS OFFERED
TABLE 474 HAMAMATSU PHOTONICS K.K.: DEALS, JANUARY 2023-JUNE 2026
TABLE 475 QUANTERIX CORPORATION: COMPANY OVERVIEW
TABLE 476 QUANTERIX CORPORATION: PRODUCTS OFFERED
TABLE 477 QUANTERIX CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026
TABLE 478 QUANTERIX CORPORATION :DEALS, JANUARY 2023-JUNE 2026
TABLE 479 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
TABLE 480 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
TABLE 481 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2023-JUNE 2026
TABLE 482 HOLOGIC, INC.: COMPANY OVERVIEW
TABLE 483 HOLOGIC, INC: PRODUCTS OFFERED
TABLE 484 HOLOGIC, INC: PRODUCT APPROVALS, JANUARY 2023-JUNE 2026
TABLE 485 3DHISTECH LTD.: COMPANY OVERVIEW
TABLE 486 3DHISTECH LTD.: PRODUCTS OFFERED
TABLE 487 3DHISTECH LTD.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2023-JUNE 2026
TABLE 488 3DHISTECH LTD.: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
TABLE 489 APOLLO ENTERPRISE IMAGING CORP.: COMPANY OVERVIEW
TABLE 490 APOLLO ENTERPRISE IMAGING CORP.: PRODUCTS OFFERED
TABLE 491 APOLLO ENTERPRISE IMAGING CORP.: PRODUCT ENHANCEMENTS, JANUARY 2023-JUNE 2026
TABLE 492 APOLLO ENTERPRISE IMAGING CORP.: DEALS, JANUARY 2023-JUNE 2026
TABLE 493 HURON TECHNOLOGIES INTERNATIONAL INC.: COMPANY OVERVIEW
TABLE 494 HURON TECHNOLOGIES INTERNATIONAL INC.: PRODUCTS OFFERED
TABLE 495 HURON TECHNOLOGIES INTERNATIONAL INC.: DEALS, JANUARY 2023-JUNE 2026
TABLE 496 HURON TECHNOLOGIES INTERNATIONAL INC.: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
TABLE 497 INDICA LABS, LLC.: COMPANY OVERVIEW
TABLE 498 INDICA LABS, LLC: PRODUCTS OFFERED
TABLE 499 INDICA LABS, LLC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
TABLE 500 INDICA LABS, LLC.: DEALS, JANUARY 2023-JUNE 2026
TABLE 501 INDICA LABS, LLC.: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
TABLE 502 OPTRASCAN: COMPANY OVERVIEW
TABLE 503 OPTRASCAN: PRODUCTS OFFERED
TABLE 504 OPTRASCAN: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
TABLE 505 OPTRASCAN: DEALS, JANUARY 2023-JUNE 2026
TABLE 506 GLENCOE SOFTWARE, INC.: COMPANY OVERVIEW
TABLE 507 GLENCOE SOFTWARE, INC.: PRODUCTS OFFERED
TABLE 508 GLENCOE SOFTWARE, INC.: PRODUCT ENHANCEMENTS, JANUARY 2023-JUNE 2026
TABLE 509 AIFORIA: COMPANY OVERVIEW
TABLE 510 AIFORIA: PRODUCTS OFFERED
TABLE 511 AIFORIA: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026
TABLE 512 AIFORIA: DEALS, JANUARY 2023-JUNE 2026
TABLE 513 AIFORIA: EXPANSIONS, JANUARY 2023-JUNE 2026
TABLE 514 PAIGE AI, INC.: COMPANY OVERVIEW
TABLE 515 PAIGE AI, INC.: PRODUCTS OFFERED
TABLE 516 PAIGE AI, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2023-JUNE 2026
TABLE 517 PAIGE AI, INC.: DEALS, JANUARY 2023-JUNE 2026
TABLE 518 PROSCIA INC.: COMPANY OVERVIEW
TABLE 519 PROSCIA INC.: PRODUCTS OFFERED
TABLE 520 PROSCIA INC.: PRODUCT ENHANCEMENTS & APPROVALS, JANUARY 2023-JUNE 2026
TABLE 521 PROSCIA INC.: DEALS, JANUARY 2023-JUNE 2026
TABLE 522 PROSCIA INC.: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
TABLE 523 EVIDENT: COMPANY OVERVIEW
TABLE 524 EVIDENT: PRODUCTS OFFERED
TABLE 525 EVIDENT: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026
TABLE 526 EVIDENT: DEALS, JANUARY 2023-JUNE 2026
TABLE 527 RISK ASSESSMENT: DIGITAL PATHOLOGY MARKET
LIST OF FIGURES
FIGURE 1 MARKET SCENARIO
FIGURE 2 GLOBAL DIGITAL PATHOLOGY MARKET, 2024-2031
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL PATHOLOGY MARKET, 2023-2026
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF DIGITAL PATHOLOGY MARKET
FIGURE 5 HIGH-GROWTH SEGMENTS IN DIGITAL PATHOLOGY MARKET, 2026-2031
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN DIGITAL PATHOLOGY MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 7 RISING PREVALENCE OF CANCER AND OTHER CHRONIC DISEASES IS INCREASING PATHOLOGY TESTING VOLUME TO DRIVE MARKET GROWTH
FIGURE 8 HARDWARE IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
FIGURE 9 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 10 DIGITAL PATHOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 11 GLOBAL CANCER INCIDENCE, 2008-2030
FIGURE 12 FDA-APPROVED PERSONALIZED MEDICINES, 2015-2024
FIGURE 13 DIGITAL PATHOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 14 DIGITAL PATHOLOGY MARKET: VALUE CHAIN ANALYSIS
FIGURE 15 ECOSYSTEM ANALYSIS
FIGURE 16 REVENUE SHIFT IN DIGITAL PATHOLOGY MARKET
FIGURE 17 RECENT FUNDING OF PLAYERS IN DIGITAL PATHOLOGY MARKET
FIGURE 18 PATENT PUBLICATION TRENDS IN DIGITAL PATHOLOGY MARKET, 2015-2026
FIGURE 19 JURISDICTION AND TOP APPLICANT ANALYSIS FOR DIGITAL PATHOLOGY MARKET
FIGURE 20 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR DIGITAL PATHOLOGY MARKET (JANUARY 2015-JUNE 2026)
FIGURE 21 MARKET POTENTIAL OF GENERATIVE AI IN ENHANCING DIGITAL PATHOLOGY
FIGURE 22 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEM
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 25 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT
FIGURE 26 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET SNAPSHOT
FIGURE 27 DIGITAL PATHOLOGY MARKET: REVENUE ANALYSIS OF TOP LISTED/PUBLIC PLAYERS, 2021-2025 (USD MILLION)
FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 29 BRAND COMPARISON
FIGURE 30 EV/EBITDA OF KEY VENDORS
FIGURE 31 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF KEY VENDORS
FIGURE 32 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 33 DIGITAL PATHOLOGY MARKET: COMPANY FOOTPRINT
FIGURE 34 COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 36 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
FIGURE 38 SECTRA AB: COMPANY SNAPSHOT (2025)
FIGURE 39 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2025)
FIGURE 40 AKOYA BIOSCIENCES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 41 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 42 HOLOGIC, INC.: COMPANY SNAPSHOT (2025)
FIGURE 43 RESEARCH DESIGN
FIGURE 44 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 45 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 46 BOTTOM-UP APPROACH
FIGURE 47 TOP-DOWN APPROACH
FIGURE 48 CAGR PROJECTIONS FROM DROC ANALYSIS OF DIGITAL PATHOLOGY MARKET
FIGURE 49 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 50 DATA TRIANGULATION METHODOLOGY
FIGURE 2 GLOBAL DIGITAL PATHOLOGY MARKET, 2024-2031
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL PATHOLOGY MARKET, 2023-2026
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF DIGITAL PATHOLOGY MARKET
FIGURE 5 HIGH-GROWTH SEGMENTS IN DIGITAL PATHOLOGY MARKET, 2026-2031
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN DIGITAL PATHOLOGY MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 7 RISING PREVALENCE OF CANCER AND OTHER CHRONIC DISEASES IS INCREASING PATHOLOGY TESTING VOLUME TO DRIVE MARKET GROWTH
FIGURE 8 HARDWARE IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
FIGURE 9 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 10 DIGITAL PATHOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 11 GLOBAL CANCER INCIDENCE, 2008-2030
FIGURE 12 FDA-APPROVED PERSONALIZED MEDICINES, 2015-2024
FIGURE 13 DIGITAL PATHOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 14 DIGITAL PATHOLOGY MARKET: VALUE CHAIN ANALYSIS
FIGURE 15 ECOSYSTEM ANALYSIS
FIGURE 16 REVENUE SHIFT IN DIGITAL PATHOLOGY MARKET
FIGURE 17 RECENT FUNDING OF PLAYERS IN DIGITAL PATHOLOGY MARKET
FIGURE 18 PATENT PUBLICATION TRENDS IN DIGITAL PATHOLOGY MARKET, 2015-2026
FIGURE 19 JURISDICTION AND TOP APPLICANT ANALYSIS FOR DIGITAL PATHOLOGY MARKET
FIGURE 20 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR DIGITAL PATHOLOGY MARKET (JANUARY 2015-JUNE 2026)
FIGURE 21 MARKET POTENTIAL OF GENERATIVE AI IN ENHANCING DIGITAL PATHOLOGY
FIGURE 22 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEM
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 25 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT
FIGURE 26 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET SNAPSHOT
FIGURE 27 DIGITAL PATHOLOGY MARKET: REVENUE ANALYSIS OF TOP LISTED/PUBLIC PLAYERS, 2021-2025 (USD MILLION)
FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 29 BRAND COMPARISON
FIGURE 30 EV/EBITDA OF KEY VENDORS
FIGURE 31 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF KEY VENDORS
FIGURE 32 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 33 DIGITAL PATHOLOGY MARKET: COMPANY FOOTPRINT
FIGURE 34 COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 36 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
FIGURE 38 SECTRA AB: COMPANY SNAPSHOT (2025)
FIGURE 39 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2025)
FIGURE 40 AKOYA BIOSCIENCES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 41 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 42 HOLOGIC, INC.: COMPANY SNAPSHOT (2025)
FIGURE 43 RESEARCH DESIGN
FIGURE 44 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 45 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 46 BOTTOM-UP APPROACH
FIGURE 47 TOP-DOWN APPROACH
FIGURE 48 CAGR PROJECTIONS FROM DROC ANALYSIS OF DIGITAL PATHOLOGY MARKET
FIGURE 49 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 50 DATA TRIANGULATION METHODOLOGY
Companies Mentioned
- DANAHER CORPORATION
- HOFFMANN-LA ROCHE LTD.
- KONINKLIJKE PHILIPS N.V.
- SECTRA AB
- HAMAMATSU PHOTONICS K.K.
- QUANTERIX CORPORATION
- FUJIFILM HOLDINGS CORPORATION
- HOLOGIC, INC.
- 3DHISTECH LTD.
- APOLLO ENTERPRISE IMAGING CORP.
- HURON TECHNOLOGIES INTERNATIONAL INC.
- INDICA LABS, LLC.
- OPTRASCAN
- GLENCOE SOFTWARE, INC.
- AIFORIA
- PAIGE AI, INC.
- PROSCIA INC.
- EVIDENT
- PATHAI, INC.
- KONFOONG BIOTECH INTERNATIONAL CO., LTD.
- MIKROSCAN TECHNOLOGIES, INC.
- MOTIC DIGITAL PATHOLOGY
- MORPHLE LABS INC.
- GRUNDIUM OY
- CURIOSIS INC.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 482 |
| Published | June 2026 |
| Forecast Period | 2026 - 2031 |
| Estimated Market Value ( USD | $ 1.58 Billion |
| Forecasted Market Value ( USD | $ 2.86 Billion |
| Compound Annual Growth Rate | 12.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
